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Abstract

Elucidation of VPS13 and PIKfyve Proteins Functioning in the Regulation of Eukaryotic
Lipid Homeostasis
PeiQi Li
2021

In eukaryotic cells, organelles are surrounded by membranes, which act as barriers to the
cytosolic environment. Each subcellular membrane has a distinct lipid composition that is
required for its unique organellar function, and is therefore is fundamental for cellular
physiology. The unique distributions of organellar lipids result from highly regulated
lipid transport networks and the activity of lipid metabolizing enzymes. Most
phospholipids are initially synthesized in the ER and transferred to different organelles
via vesicular or non-vesicular lipid transport pathways. Lipid transfer proteins (LTPs)
localized at membrane contact sites mediate non-vesicular lipid transport. They contain a
hydrophobic cavity to solubilize the hydrophobic “tail” of lipids. They either function as
“shuttles” that typically ferry a single lipid at a time between membranes, or “bridges”
that harbor hydrophobic channels along which more than one lipid can move between
membranes at a time. For the first part of my thesis, I investigated the structure and
function of VPS13, a novel lipid transfer “bridge” protein, and showed that the protein
accommodates a 16nm long hydrophobic lipid transfer channel that mediates bulk lipid
1

transfer. My work marked the identification of the first lipid transfer bridge in eukaryotes
and raised several still open questions regarding the molecular mechanism of bridge-like
LTPs. I further investigated VPS13’s WD40 domain to provide insights into how VPS13
interacts with membranes at membrane contact sites.
The second part of my thesis focused on the modification of phosphatidylinositol (PI),
which is essential in signalling. Phosphorylation on different positions of the head group
of PI generates several phosphoinositide (PIP) species. Each of them has a unique
subcellular localization. PI(3,5)P2 is one of the signature phosphoinositides in
endolysosomal membranes, whose level is tightly upregulated in response to stimuli.
PI(3,5)P2 is solely synthesized by the PIKfyve lipid kinase and its turnover is catalyzed
by the Fig4 lipid phosphatase. Intriguingly, the two proteins, although catalyzing
antagonistic reactions, are in the same complex together with a third protein, the scaffold
Vac14. Little is known about how the activities of PIKfyve and Fig4 are regulated to
prevent futile consumption of ATP. Combining structural and biochemistry studies, I
gained insights into the overall architecture of the PIKfyve complex and into the
regulatory mechanisms that govern PIKfyve and Fig4 activities.
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Chapter 1 Introduction
Abbreviations
PC: phosphatidylcholine; PE: Phosphatidylethanolamine; PS: Phosphatidylserine; PI:
Phosphatidylinositol; GPL: glycerophospholipid; ER: Endoplasm reticulum; PM: plasma
membrane; MCS: membrane contact site; NVJ: nucleus–vacuole junction; LTP: lipid
transfer protein; OSBP: Oxysterol-binding protein; ORP: OSBP related protein; PITP:
Phosphatidylinositol transfer protein; SMP: Synaptotagmin-like mitochondrial-lipidbinding protein; TULIP: tubular lipid-binding domain protein; CL: Cardiolipin; LPS:
lipopolysaccharide

Chapter 1.1 Glycerol lipids and membranes
Lipids are a category of macromolecule defined by their inability to mix with polar
solvents. They function as primary chemical energy storage molecules and are essential
nutrients for human health. At the molecular level, they are the primary building blocks
of cellular and subcellular membranes. Cells are surrounded by membranes, which act as
barriers to the extracellular environment. Compartmentalization within eukaryotic cells
into membrane-bound organelles allows for micro-environments adapted for specialized
functions. The lipid compositions of different organelles are distinct, and the lipid
composition of organelles can even change in response to stimuli. Membrane lipids are
9

highly diverse, with potentially 100,000 lipid species, and 5% of our genes are related to
lipid synthesis (Frolov, Shnyrova, & Zimmerberg, 2011; Shevchenko & Simons, 2010;
van Meer, Voelker, & Feigenson, 2008). Maintaining the lipid homeostasis of organellar
membranes is fundamental for cellular life.

Chapter 1.1.1 Glycerophospholipid basic structure, classification and character

The lipid components of eukaryotic membranes can be classified into two major
categories, glycerolipids and sphingolipids, based on their backbones (Figure 1.1). As
implied by their name, glycerolipids have a glycerol backbone, with two fatty acid lipid
groups attached to the C1 and C2 positions
of glycerol known as hydrophobic “tail.”
The C3 position is also modified via the
addition of a polar “headgroup” moiety to
give rise to different sub-classes of
glycerolipid. Glycerophospholipids have a
phosphate ester at the C3 position linked to
choline, ethanolamine, serine, or inositol to
give rise to phosphatidylcholine (PC),
phosphatidylethanolamine (PE),
Figure1.1: Overall structure of

phosphatidylserine (PS), or

Glycerolipids and Sphingolipids

phosphatidylinositol (PI). Variability in the
size or electric charge in the headgroup, or

length or saturation in the “tail,” gives these lipids different properties. Sphingolipids use
10

sphingosine as the backbone with a long saturated fatty acid linked via amide linkage
(Figure 1). Ceramide and sphingomyelin are common sphingolipids, with different head
groups (Holthuis & Menon, 2014; van Meer & de Kroon, 2011).
Due to the amphiphilic property of membrane lipids, they naturally form a double layer
membrane structure with “head” groups facing towards the cytosolic environment and
“tail” groups embedded inside. PC is the most abundant phospholipid in membrane
bilayers, accounting for more than 50% of membrane lipids. Because the diameters of the
“head” and “tail” groups are similar, PC is cylindrical, allowing it to assemble into
bilayers under normal physiological conditions. Non-bilayer lipids such as PE and
diacylglycerol (no head group) are cone-shaped due to their relatively small “head” and
wide “tail,” and so do not form a stable membrane bilayer by themselves. Their conical
shape introduces packing defects into membranes, promoting the binding of peripheral
membrane proteins, and induces membrane curvature. The head group of PS is negatively
charged, allowing it to bind peripheral membrane proteins via electrostatic interactions
(Chernomordik, Zimmerberg, & Kozlov, 2006; Dowhan, 1997; Frolov et al., 2011; Lee,
2004). The PI headgroup can be rapidly phosphorylated and dephosphorylated to
generate seven different species of phosphoinositide lipids that specifically recruit
adaptor proteins during signal transduction (Balla, 2013).
Each subcellular membrane has a distinct membrane lipid composition fundamental for
cellular physiology (Frolov et al., 2011). Global lipid composition largely determines the
physical properties of cellular membranes including overall shape, curvature, packing,
and tension. In general, the endoplasmic reticulum (ER) contains mostly unsaturated
glycerophospholipids, while cholesterol and sphingolipids are enriched at the plasma
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membrane (PM). Mitochondrial membranes are enriched in PE and cardiolipin. The
seven phosphoinositides have distinct organellar distributions (Harayama & Riezman,
2018; van Meer & de Kroon, 2011). The unique distributions of bulk and signaling lipids
result from directionality and selectivity in lipid transfer, and the activity of lipid
metabolizing enzymes. Overall, changes in lipid composition are carefully tuned and
tightly regulated (van Meer et al., 2008).

Chapter 1.1.2 Lipid synthesis and transportation

Lipid synthesis is compartmentalized to different organelles due to the localization of
specific enzymes. The ER is the primary site for the synthesis of PC, PA, PI, and PS,
while PE and cardiolipin are synthesized in mitochondria (Yang, Lee, & Fairn, 2018).
Most other biological membranes, such as the PM and endosomes, do not have the
capability to synthesize glycerophospholipids and must acquire newly synthesized lipids
from ER. In eukaryotic cells, there are two major mechanisms for lipid transport:
vesicular transport via the secretory pathway or protein-mediated lipid transport at socalled membrane contact sites (MCSs). Vesicular transport in the secretory pathway has
long been studied as a means of bulk lipid transfer between the ER, Golgi, endosomes,
and PM. Non-vesicular protein-mediated lipid transfer also takes place between
organelles of the secretory pathway but is particularly important for organelles not
connected to the secretory pathway, such as mitochondria and chloroplasts (Scorrano et
al., 2019). Non-vesicular protein-mediated lipid transfer is more selective for fine-tuning
membrane compositions and responds quickly to stimuli, versus having to travel via the
12

secretory pathway. What has been learned about lipid transfer at MCSs in recent years
will be discussed in more detail below.

Chapter 1.1.3 Membrane contact sites

The close proximity between the ER and mitochondria was first observed in the 1950s in
liver cells after starvation and refeeding (Bernhard & Rouiller, 1956). Later, the concept
of membrane contact sites started to emerge with discoveries such as ER and PM
connections in skeletal muscle cells (Kawamoto, Brunschwig, Kim, & Caswell, 1986)
and the identification of the nuclear–vacuolar junction (NVJ) in yeast (Pan et al., 2000).
The study of MCSs has gained momentum in the last ten years. Membrane contacts are
defined as sites where the membranes of two organelles come into close proximity
without fusing. Although it was initially thought that MCSs always involve the ER, it is
now clear that any two organelles can form contacts; for example, there are contacts
between lipid droplets and mitochondria, between mitochondria and the PM, and between
mitochondria and peroxisomes (Eisenberg-Bord, Shai, Schuldiner, & Bohnert, 2016). The
distance between two membranes is largely determined by tethering proteins linking the
membranes and is typically between 10 -30 nm. Contact sites mediate the transportation
of lipids, ions, amino acids, and metals; the transmission of signaling information for the
downstream events such as autophagy; and can regulate organelle morphology (Friedman
et al., 2011; Knoblach & Rachubinski, 2015; Lewis, Uchiyama, & Nunnari, 2016).
Contacts have also been proposed to allow enzymes in one membrane to access
substrates in trans on another organelle (Eden, White, Tsapara, & Futter, 2010; Stefan et
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al., 2011). Each contact site has unique functions, with a unique set of proteins that carry
out these functions (Muik et al., 2011; Stathopulos, Zheng, Li, Plevin, & Ikura, 2008).
One of the major functions of MCSs is lipid transfer, which occurs in response to stimuli,
either specifically or non-specifically. The importance of lipid transfer has been
elucidated at ER and mitochondria contact sites. Mitochondria purified from rat liver
cells contained a fraction of ER enriched with lipid biosynthesis enzymes (Vance, 1990).
It has long been known that in mammalian cells, PS is synthesized in mitochondria, and
then transferred back to the ER to synthesize PE. Also, cardiolipin is solely synthesized
in the mitochondria and transferred back to the ER for the synthesis of PA. To fulfill the
synthesis of these lipids, they need to be transferred between the ER and mitochondria in
a selective and specific fashion. Furthermore, mitochondria need bulk lipids from the ER
to maintain expansion. Given that mitochondria are not connected to vesicular transport,
the close apposition between the ER and mitochondria serves as an ideal hub for highvolume lipid transfer. Non-vesicular lipid transport is mediated by lipid transfer proteins
(LTPs) (Petrungaro & Kornmann, 2019).

Chapter 1.2 Lipid transfer protein families in cells
Because of their large hydrophobic moieties, lipids are poorly soluble in aqueous
environments, and in vitro studies demonstrate that spontaneous lipid exchange between
even closely apposed membranes is too slow to be physiologically relevant (McLean &
Phillips, 1984). Lipid transfer proteins extract lipids from membranes and solubilize them
to accelerate lipid exchange between membranes. The number of known LTPs has
greatly risen in the past decade and are found in all organisms, from bacteria to humans.
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LTPs typically have a hydrophobic cavity that binds the hydrophobic portions of the lipid
normally embedded in the lipid bilayer. Most LTPs involved in glycerolipid transfer that
have been studied so far are not specific for acyl chain length, where the acyl chains bind
in the hydrophobic cavity, but many recognize a specific headgroup. In general, LTPs fall
into two main categories: “shuttles” and “bridges.” They differ in hydrophobic cavity size
and mechanism. Most eukaryotic LTPs identified so far are “shuttles” that ferry a single
lipid at a time between membranes, and the cavity is normally selective for certain lipid
species; in some cases, they exchange two distinct lipid species between membranes.
Instead, “bridges” are thought to form a static hydrophobic conduit to allow for bulk
lipids moving along within. It has been speculated that “bridges” have no selectivity since
lipids are not occupying certain binding sites inside of the hydrophobic conduit (Figure
1.2). Indeed, our understanding of the molecular mechanism of LTPs is still limited, but
the identification of several LTPs has improved our knowledge of the field. Several
typical LTP families will be discussed below.

Figure 2: Comparison of shuttle model and bridge model of lipid transfer protein
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Chapter 1.2.1 Shuttle-like lipid transfer proteins

OSBP-related protein family

Oxysterol-binding proteins (OSBP) and OSBP-related proteins (ORP) are conserved in
all eukaryotes (Kentala, Weber-Boyvat, & Olkkonen, 2016). In humans, they are encoded
by 12 genes and classified into six distinct subfamilies (Kentala et al., 2016), and localize
to ER-PM, ER-Golgi, ER-late endosome, and ER-lipid droplet contact sites. All proteins
in the ORP family have an ORD (OSBP-related domain) lipid-binding module.
Additionally, some of the proteins also contain motifs for correct localization,
recognizing specific phosphoinositides or proteins enriched at particular contact sites
(Olkkonen, 2015). Several ORD domains of the ORP protein family specifically interact
with two species of lipid; one of these is a phosphoinositide and the other is sterol or PS
(Wong, Gatta, & Levine, 2019). These proteins mediate the exchange of lipids between
membranes: they transport sterol or PS against a gradient by harnessing the energy
present in the phosphoinositide gradients in the two membranes. For example, OSBP
transfers cholesterol from the ER to the Golgi, where sterol is enriched, and PI4P from
the Golgi, where PI4P is enriched, in the opposite direction (Mesmin et al., 2013). PI4P
flowing forward in the gradient provides the energy for transferring cholesterol
contrariwise to its gradient. ORP1 and ORP2 facilitate cholesterol transport between the
ER and other organelles, including lipid droplets and late endosomes (Hynynen et al.,
2009; Rocha et al., 2009). The ORP protein family participates in many cellular
processes, including phosphoinositide and neutral lipid metabolism, apoptosis, and viral
replication (Olkkonen, 2015).
16

PITP and Sec14 protein family

Phosphatidylinositol transfer proteins (PITPs) bind PI and PC, mediating their transfer or
exchange between organellar compartments (Hsuan & Cockcroft, 2001). Sec14 and PITP
family proteins are structurally distinct but functionally interchangeable. In humans, PITP
proteins are divided into two classes. Class I proteins are compact, comprising only a
lipid binding module, the so-called PITP domain. Class II proteins have additional
modules, such as DDHD and LNS2 domains responsible for interacting with PM lipids,
and some contain an FFAT motif to attach them to the ER (Cockcroft, 2012; Saheki &
De Camilli, 2017). The hydrophobic cavity of the PITP domain binds either PI or PC,
though the binding affinity to PI is 16-times higher than PC. This is due to a series of
conserved residues in the cavity that form hydrogen bonds to the inositol group of PI
(Hsuan & Cockcroft, 2001). Class II PITP proteins are thought to facilitate non-vesicular
PI transfer at ER-PM contact sites (Saheki & De Camilli, 2017). They are proposed to
present PI to lipid kinases at the PM during phosphoinositide synthesis there (Cockcroft,
2012). PITP may be evolutionarily related to the START family of lipid transporters, but
binds to different lipids species (Radauer, Lackner, & Breiteneder, 2008).

SMP domain containing protein family (TULIP)

The synaptotagmin-like mitochondrial-lipid-binding protein (SMP) domain belongs to a
tubular lipid-binding (TULIP) domain superfamily and is conserved across eukaryotes
(Kopec, Alva, & Lupas, 2010). The SMP domain is characterized by an extended barrel
shape with an inner cavity lined with hydrophobic residues that binds lipids (Reinisch &
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De Camilli, 2016; Schauder et al., 2014). SMP domain proteins localize to different
contact sites to promote lipid transfer between the ER and PM, or between the ER and
other organelles. Several SMP domain-containing proteins have been identified to
improve our knowledge about this protein family. The E-syt proteins, known as tricalbins
in yeast, go to ER-PM contacts. E-syts comprise an N-terminal hairpin that is inserted
into the membrane of the ER, an SMP domain, and finally 3-5 C2 domains at their Cterminus (Schulz & Creutz, 2004). The C2 domains interact with the PM depending on
cytosolic calcium levels or interact with PI(4,5)P2, a phosphoinositide enriched at the
PM. E-syt2 dimerizes via its SMP domains, which form a 90 Å tube-like structure that
can accommodate four glycerolipids at a time (Reinisch & De Camilli, 2016; Schauder et
al., 2014). Because the SMP dimer is too short to bridge the space between membranes at
contact sites, it was proposed to act as a shuttle, although it remains possible that it could
be a bridge-like transporter. The E-Syts seem to interact with glycerolipids nonspecifically, and their function in cells is not well understood. They are proposed to
function in recycling diacylglycerol produced at the PM during phosphoinositide
signaling to the ER, in order to terminate the signal (Saheki et al., 2016).
Another SMP-domain protein that localizes to ER-PM contact sites, present only in
metazoa and expressed in neuroendocrine cells, is TMEM24. It has an N-terminal
transmembrane helix that anchors it to the ER, followed by the SMP domain, a C2
domain of a still unknown function, and finally a C-terminal polybasic segment that
interacts with negatively charged lipids in the PM. The SMP domain in TMEM24
preferentially binds phosphatidylinositol and plays a role in replenishing PI, which is
made in the ER, at the PM during insulin secretion (Lees et al., 2017).
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The ERMES complex localizes to ER-mitochondrial contact sites in yeast. The complex
comprises four core proteins -- Mdm12, Mdm10, Mmm1, and Mdm34 -- and two
peripheral proteins, Gem1 and Tom7 (Stroud et al., 2011). Mdm12, Mmm1, and Mdm34
have SMP domains (AhYoung, Lu, Cascio, & Egea, 2017). Mdm12 and Mmm1 form a
210 Å-long tubular heterotetramer. An in vitro study using purified protein found that
Mdm12 and Mmm1, but not Mmm1 alone, is able to transfer lipids between membranes,
indicating that the formation of the tetramer is essential for lipid transfer (AhYoung et al.,
2015; Jeong, Park, Jun, & Lee, 2017; Kawano et al., 2018). Whether and how Mdm34
associates with the tetramer is unknown. Also unknown is whether ERMES behaves as a
shuttle or instead as a bridge-like protein (Wong et al., 2019). Mdm10 is an integral
membrane protein embedded in the mitochondrial outer membrane (Sogo & Yaffe,
1994), and Gem1 is a GTPase with a transmembrane helix anchored in the mitochondrial
outer membrane (Kornmann, Osman, & Walter, 2011).
The ERMES complex mediates glycerolipid transfer between the ER and mitochondria
and is thought to be required for PS transfer from the ER, where PS is synthesized, to
mitochondria, where PS is a precursor for PE. PE is subsequently transferred back to the
ER, where it is converted to PC. Supporting a role for ERMES in PS transport, a
mutagenesis study showed that PS transfer from the ER to mitochondria is decreased in
yeast that does not contain Mdm12 and Mmm1 (AhYoung et al., 2015; Jeong et al., 2017;
Kawano et al., 2018).
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Chapter 1.2.2 Bridge-like lipid transfer proteins

LPS transporter

Apart from requiring a small volume of certain lipid species, organelles such as
mitochondria need bulk lipids from ER to maintain membrane expansion, which is also
true for the autophagosome membrane expansion during autophagy and the prospore
membrane expansion during sporulation in yeast. It has been widely speculated that such
bulk transfer could be mediated by bridge-like LTPs, which form hydrophobic conduits
along which lipids can traverse the cytosol between membranes. Some SMP proteins, in
particular the ERMES complex, have been proposed to form such bridges (Kornmann,
2020), although this is still under discussion. In general, until our work, the best
characterized bridge-like protein was identified from bacteria.
At the outer membrane of gram-negative bacteria, lipopolysaccharide (LPS) functions as
a barrier for protection from extracellular hazards, such as antibiotics. The LPS
transporter transfers LPS, which is made at the inner membrane of bacteria, to the outer
membrane, and maintains the asymmetric distribution of LPS. The LPS transporter is
composed of seven proteins, LptA – LptG, which localize between inner and outer
membranes. The LptA protein consists of a β-sheet curved to adopt a taco shape whose
inner surface is lined by hydrophobic residues. Several LptA proteins linked together
head-to-tail form a 21 nm-long hydrophobic bridge across the intra-membrane space. The
bridge accommodates the hydrophobic tail of LPS, enabling the movement of LPS
between the inner and outer membrane. Other Lpt proteins in the complex mediate LPS
extraction, insertion, and transfer between membrane leaflets (Wong et al., 2019). The
20

complex utilizes two ATP hydrolysis steps to provide energy, driving LPS against a
gradient. The entire LPS transfer bridge system is critical for maintaining the
asymmetrical distribution of LPS in E. coli (Okuda, Freinkman, & Kahne, 2012).

Chorein-N domain protein family

Together with our collaborators, our lab recently discovered that large proteins that have
a chorein-N motif belong to a novel family of lipid transport proteins. The chorein-N
motif is a ~120 amino acid sequence at the N-terminus of these proteins. Three major
proteins have been identified belonging to this family: VPS13 (Vacuolar protein sortingassociated protein 13) (Ueno et al., 2001), ATG2 (autophagy-related protein 2) (GomezSanchez et al., 2018), and SHIP164 (Syntaxin 6 Habc‐interacting protein of 164 kDa)
(Otto, Razi, Morvan, Stenner, & Tooze, 2010). Several bacterial proteins may also belong
to this family based on bioinformatics studies (Levine, 2019). VPS13 and ATG2 are the
best-studied members of this family. ATG2 plays a critical role in the early steps of
autophagy, and VPS13 is of high interest because dysfunction in any four human genes
VPS13 A-D (Velayos-Baeza, Vettori, Copley, Dobson-Stone, & Monaco, 2004) lead to
severe neurological disorders, including chorea-acanthocytosis, Cohen syndrome, an
early-onset form of Parkinson’s disease, and ataxia (Lesage et al., 2016; Rampoldi et al.,
2001; Seifert et al., 2011; Seong et al., 2018).
VPS13 was first identified via yeast genetics, where a VPS13 mutation strain was found
to bypass ERMES deficiency (Lang, John Peter, Walter, & Kornmann, 2015). Since
ERMES is not conserved in metazoa, VPS13 was hypothesized to substitute for ERMES
in higher eukaryotes. VPS13 has a PH-DH domain at the C-terminus that is proposed to
21

mediate interaction with membranes (Kumar et al., 2018). Upstream of the PH-DH
domain is a WD40-like domain. In yeast, this domain has been shown to interact with
PxP motifs present in organellar receptor proteins, and likely also functions in VPS13
localization to particular contact sites (Bean et al., 2018). A small segment at the Nterminus that includes the chorein-N motif (~10% of the whole protein), VPS13crystal,
forms a scoop-like structure with the entire inner surface lined with hydrophobic
residues. A longer fragment of the N-terminus of VPS13 (VPS13α) can bind more lipids
compared with VPS13crystal, suggesting that the complete lipid transfer module extends
beyond the crystallized fragment. Interestingly, VPS13α purified from a human cell line
was able to bind tens of lipids per molecule, as quantified by mass spectrometry (Kumar
et al., 2018), versus previously identified lipid transfer modules that typically bind 1-2
lipids. These findings suggest that VPS13 differs from conventional shuttle-like lipid
transfer proteins and instead might utilize a bridge-like mechanism similar to the LPS
transporter. To test this hypothesis, I combined structural and biochemical studies to
investigate the molecular function of VPS13.
The autophagy protein ATG2 is required for the growth of autophagosome membranes
(Gomez-Sanchez et al., 2018). ATG2 has an N-terminal chorein-N motif and a Cterminal PH-DH domain, similar to VPS13. While ATG2 does not have a WD40-like
domain, it interacts with WD40 proteins, including Atg18 in yeast and the WIPI proteins
in mammals (Kotani, Kirisako, Koizumi, Ohsumi, & Nakatogawa, 2018; Zheng et al.,
2017). The N-terminal portion of ATG2 adopts a scoop-like fold similar to VPS13, with
the entire inner surface lined with hydrophobic residues (Osawa et al., 2019). In both
VPS13 and ATG2, the chorein-N motif is followed by mostly -strand sequences, and

22

low resolution cryo-EM studies suggest, intriguingly, that these fold into a taco shape that
might function in lipid transport by the bridge-like mechanism (Valverde et al., 2019).
Such a structural feature can mediate lipid transfer in vitro and is critical for the
expansion of the autophagosome membrane in vivo (Valverde et al., 2019). Localizing to
different MCSs, VPS13 and ATG2 have high similarity structurally and functionally.
In the first part of my thesis work, I showed by cryo-EM that there is a hydrophobic
channel in VPS13, at least 16nm long, strongly supporting that proteins from this family
could function as lipid transfer bridges. The structure raised several questions regarding
the molecular mechanism of lipid transfer bridges. How is the directionality of bulk lipid
flow determined, and what provides the energy for driving lipid flow?
A more detailed understanding as to the mechanisms underlying protein-mediated lipid
transfer, especially for bridge-like LTP’s, is still lacking. Limitations in technology make
it difficult to trace the entire process of lipid extraction, lipid flow through the
hydrophobic conduit, and lipid insertion. However, it possible to speculate about some
critical steps. It not hard to understand that lipid transfer proteins decrease the activation
energy of the lipid extraction process by providing a hydrophobic environment. However,
the energy provided by LTPs is not enough. (Moser von Filseck, Vanni, Mesmin,
Antonny, & Drin, 2015). The biophysical properties of donor membranes also affect lipid
desorption and lipid delivery. The regions of ER that form close contacts with other
organelles contain specialized lipids compositions and thus differ in membrane properties
such as lipid packing, curvature, and tension (King, Sengupta, Seo, & LippincottSchwartz, 2020). It is intriguing to speculate that the properties of the membrane are
regulated by integral and peripheral membrane proteins. VPS13 is recruited to
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membranes via binding with several adaptor proteins (Bean et al., 2018; Kumar et al.,
2018). Little is known about the functions of these adaptor proteins besides tethering
LTPs. It has been speculated that protein adaptors are required to destabilize donor
membranes, making it easy for lipid desorption (Petrungaro & Kornmann, 2019), and to
scramble lipids to the inner leaflet at acceptor membranes to release tension on the outer
leaflet after receiving bulk lipids. Indeed, several recent studies have demonstrated that
ATG2 interacts directly with ATG9 (Guardia et al., 2020), and that ATG9 functions as a
scramblase to facilitate autophagosome inner leaflet membrane expansion (Maeda et al.,
2020; Matoba et al., 2020). Moreover, reminiscent of the LPS transporter, lipid transfer
bridges might acquire energy from the hydrolysis of ATP. However, our understanding of
this process is still limited and the investigation of interacting partners is needed.

Chapter 1.3 Phosphatidylinositol and phosphoinositide
Overview of signaling function
Phosphoinositides are low-abundance but essential
signaling lipids. They are derived from PI, which is
synthesized in the ER and then redistributed to other
organelles either via vesicular trafficking or LTPs. At
different organelles, PI is phosphorylated at its 3,4, or
5 positions on the inositol ring, resulting in the
production of seven
phosphoinositides: PI(3)P,

Figure 1.3: Overall structure of Phosphatidylinositol

PI(4)P, PI(5)P, PI(3,4)P2,
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PI(3,5)P2, PI(4,5)P2, and PI(3,4,5)P3 (Figure 1.3). These phosphoinositides are distributed
unevenly at subcellular membranes due to modification by lipid kinases and phosphatases
resident at different compartments. PI(4)P is the signature phosphoinositide on the Golgi
apparatus, while the derivatives PI(4,5)P2, PI(3,4)P2, and PI(3,4,5)P3 mainly reside at the
PM. PI(3)P and PI(3,5)P2 are enriched at, and critical for the biology of, endo-lysosomal
membranes. Phosphoinositides recruit specific effector proteins to their organelles at
specific times. The PI effectors, in turn, regulate the activity of the cytoskeleton,
membrane contact sites, and ion channels, and control signaling pathways (Schink, Tan,
& Stenmark, 2016) (Di Paolo & De Camilli, 2006; Jin, Lang, & Weisman, 2016).

Chapter 1.3.1 PI(3,5)P2 – phenotype and function, synthesis

PI(3,5)P2 is the least abundant phosphoinositide, accounting for only 0.05% - 0.1% of
total PIPs, and localizes to the endo-lysosomal system. It regulates many processes,
including lysosomal ion homeostasis, lysosome acidification, retrograde trafficking
between the Golgi and lysosomes, membrane fission and fusion, autophagy (Hasegawa,
Strunk, & Weisman, 2017), and viral replication (Qiu et al., 2018). PI(3,5)P2 levels are
highly dynamic in response to stimuli, such as insulin or growth factors in human cells,
or hyperosmotic shock in yeast and plant cells (Dove et al., 1997). PI(3,5)P2 levels are
correlated with endo-lysosomal size in human and vacuolar compartment sizes in yeast.
(Gary, Wurmser, Bonangelino, Weisman, & Emr, 1998; Ikonomov, Sbrissa, & Shisheva,
2001). In humans, PI(3,5)P2 mis-regulation causes developmental disorders, including
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Charcot-Marie-Tooth syndrome type 4J and forms of amyotrophic lateral sclerosis (Chow
et al., 2009; Chow et al., 2007).

Chapter 1.3.2 regulation of PI(3,5)P2 level

In yeast, PI(3,5)P2 levels increase 20-fold within 5 minutes in response to hyperosmotic
shock (Duex, Nau, Kauffman, & Weisman, 2006), resulting in activation of upstream
effectors. Such a fast response to stimuli indicates that levels of PI(3,5)P2 are tightly
regulated. PI(3,5)P2 is synthesized solely from PI3P by the lipid kinase PIKfyve.
PIKfyve has an FYVE domain at its N-terminus, which recognizes PI3P at endolysosomes and localizes PIKfyve, a CCT (chaperone-containing TCP1) domain, and a
CCR (conserved cysteine-rich) domain with unknown function. The kinase domain is at
the very C-terminus. All the domains are conserved across eukaryotes, suggesting
conserved mechanisms of action, although little was known about the domain
arrangement in the context of full-length PIKfyve (Jin et al., 2016). Turnover of PI(3,5)P2
is catalyzed by Fig4, which contains a phosphatase with a Sac homology domain.
Paradoxically, the proteins PIKfyve and Fig4, although catalyzing antagonistic reactions,
exist in a single complex together with the scaffolding protein Vac14 (Botelho, Efe, Teis,
& Emr, 2008). It was long unclear how the activities of PIKfyve and Fig4 are regulated
within the complex to prevent futile hydrolysis of ATP. Further, while Fig4 catalyzes the
dephosphorylation of PI(3,5)P2, deletion of Fig4 causes defects in the upregulation of
PI(3,5)P2 in response to hyperosmotic shock in yeast (Duex et al., 2006), suggesting that
PIKfyve might require Fig4 for activity.
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In the second part of my thesis work, we found that the PIKfyve complex comprises five
copies of the scaffolding protein Vac14 and one copy each of the PIKfyve and Fig4. In
the ternary complex, Fig4 is active as a lipid phosphatase, while PIKfyve cannot access
membrane-incorporated phosphoinositides due to conformational constraints. The
phosphoinositide-directed activities of both PIKfyve and Fig4 are regulated by proteindirected activities. In detail, PIKfyve was previously reported to also act as a protein
kinase, and its autophosphorylation was found to repress its lipid kinase activity (Sbrissa,
Ikonomov, & Shisheva, 2000). We found that its autophosphorylation stimulates Fig4
lipid phosphatase activity. Further, we found that in addition to its role as a lipid
phosphatase, Fig4 is also a protein phosphatase acting on PIKfyve to stimulate its lipid
kinase activity. This explains why catalytically active Fig4 is required for maximal
PI(3,5)P2 production in vivo. Our work greatly advances the knowledge of the overall
architecture and regulatory mechanism of the PIKfyve complex. However, we were
unable to capture other conformations of the PIKfyve complex, which should exist as
indicated by our biochemistry assay. Additionally, our work was in the context of
purified PIKfyve complex that lacked the participation of other interacting partners as it
normally occurs in vivo. Further investigations of the PIKfyve complex in a more
biologically relevant context will advance our knowledge of lysosomal membrane
biology.
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Abstract. A single particle cryo-EM reconstruction of a ~160 kDa N-terminal fragment
of the lipid transport protein VPS13 reveals a ~160 Å long channel lined with
hydrophobic residues suitable for solubilizing multiple lipid fatty acid moieties. The
structure suggests that VPS13 and related proteins, like the autophagy protein ATG2, can
act as bridges between organelle membranes to allow bulk lipid flow between organelles.

Introduction.
In eukaryotic cells, most membrane lipids are synthesized in the endoplasmic reticulum
(ER), then distributed to other organelles. This occurs through vesicular trafficking or
else via protein-mediated lipid transport at membrane contact sites, where two organelles
are closely apposed. The eukaryotic lipid transport proteins characterized so far are
thought mostly to act as shuttles that extract and solubilize lipids from the membrane of
the donating organelle, ferry these through the cytosol, then deposit them in the
membrane of the acceptor organelle (Wong et al., 2019). Typically, these proteins
comprise domains resembling lidded tea cups, each with a hydrophobic cavity that
accommodates one or two lipid molecules. Here we describe a different architecture for
large proteins in the VPS13 family of lipid transporters, whose features suggest that these
proteins may instead function as bridges along which bulk lipid can traverse the cytosolic
space between membranes. The VPS13 proteins themselves, present in all eukaryotes, are
of intense biomedical interest because their loss-of-function mutations give rise to severe
neurodegenerative diseases, including chorea acanthocytosis and an early onset version
of Parkinson’s disease (Lesage et al., 2016; Rampoldi et al., 2001; Ueno et al., 2001). In
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metazoa, they are proposed to mediate lipid exchange between the ER and mitochondria,
the endo/lysosomal system, or lipid droplets (Kumar et al., 2018). In budding yeast,
Vps13p plays a role in the biogenesis of the prospore (Park and Neiman, 2012), a double
membrane structure that surrounds the four meiotic products during sporulation. Lipid
transport by the VPS13-like protein ATG2 is required for the biogenesis of another
double membrane structure, the autophagosome (Valverde et al., 2019).

Results and Discussion.
The lipid transport functionality of VPS13 resides in a ~200 kDa N-terminal portion rich
in ß-strand structure, whereas its C-terminus is predicted to comprise a WD40 and a PH
domain critical in targeting the protein to organelle contact sites (Bean et al., 2018;
Kumar et al., 2018). To better understand how VPS13 mediates lipid transfer, we imaged
an N-terminal fragment of Chaetomium thermophilum VPS13, VPS131-1390 comprising
residues 1-1390, by single particle cryo-electron microscopy, to obtain a 3D
reconstruction at a nominal resolution of 3.75 Å (Fig. 2.1). The ß-strands in VPS131-1390
form an extended sheet curved to resemble an open-ended basket, which is twisted by
~90° along its length. α-helices in the loops between strands trim a long edge of the
basket and also assemble into a basket “handle”. Because the fragment lacks a protein
core, so that most side chains and long loops connecting secondary structure elements are
solvent exposed and poorly resolved, it has not been possible to confidently trace the
polypeptide chain. We were able to assign a Cα trace for residues 650-830 to the middle
portion of the basket (shaded blue region in Fig. 2.1B), which corresponds to higher
resolution regions of the map. Moreover, we can definitively dock the crystal structure of

37

the very N-terminus of the C. thermophilum protein, VPS131-335 comprising residues 1335 (PDBID 6CBC) (Kumar et al., 2018), into density at one end of the basket (Fig. 1A,
2A). Two helical segments (residues 99-118, disordered in 6CBC, and 300-322) were
repositioned with respect to the crystal structure to form part of the basket handle (Fig.
1A, 2A). The VPS131-335 fragment is shaped like a scoop, and its concave surface is
lined exclusively with hydrophobic residues (Kumar et al., 2018). Docked into the EM
reconstruction, this hydrophobic surface faces the basket interior. As in this smaller
fragment, the remaining ß-strands in Vps131-1390 feature alternating hydrophobic and
hydrophilic residues, and it is probable that as in the smaller fragment the hydrophobics
will face the basket interior while the hydrophilics are solvent exposed. Thus, VPS131-1390
forms a long channel well suited for solubilizing, as reported before 5, tens of lipid fatty
acid moieties. The hydrophilic headgroups of the lipids would extrude into solvent. An
interesting feature of VPS131-1390 is its asymmetry along its longitudinal axis: the channel
is approximately twice as wide at the end harboring Vps131-335 as at the other, where its
width across (~12 Å from Cα to Cα) resembles that of a more typical lipid transport
module. A 3D cryo-EM reconstruction of ATG2, determined at ~15 Å resolution,
suggests that ATG2 has a long channel similar to that in VPS131-1390 (Valverde et al.,
2019).
Like ATG2 (Chowdhury et al., 2018; Gomez-Sanchez et al., 2018; Kotani et al., 2018),
VPS13 is proposed also to act as a tether, since its overexpression promotes the formation
of more numerous and more extensive membrane contacts (Kumar et al., 2018; Lang et
al., 2015). Via its C-terminal WD40 domain, VPS13 can interact with membrane
associated proteins containing a proline-X-proline motif (Bean et al., 2018); and a FFAT
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motif in human VPS13A and VPS13C, which we would tentatively place in or near the
“handle” in the VPS131-1390 reconstruction, interacts with the ER-anchored VAP protein
(Kumar et al., 2018). This suggests that at contact sites VPS13 might be arranged with its
length approximately normal to the membrane planes, so that lipids would access the
hydrophobic cavity via its ends, one of which is formed by VPS131-335, then travel
between membranes through the channel (Fig. 2.2B). In this “bridge” model, lipids move
through the entire length of the channel, whereas in an alternative “shuttle” model, the
lipids would be stationary within the channel as the protein carries them between
membranes. If the “bridge” model is correct, then rendering a band within the VPS13
channel impassible to lipids, by replacing hydrophobic with hydrophilic residues unable
to solubilize fatty acid moieties, should disrupt lipid transfer. If instead VPS13 acts as a
shuttle, then lipid transport should be largely unaffected by the mutations, as most of the
hydrophobic channel is unaltered and would retain the ability to bind lipids. Since VPS13
function is required for prospore formation in yeast (Park and Neiman, 2012), and strains
lacking the protein fail to sporulate (Enyenihi and Saunders, 2003), we tested mutant
versions of VPS13 for their ability to rescue sporulation in vps13α strains. In one mutant,
guided by the crystal structure, we altered a band of residues at one end of the channel in
the N-terminal portion of S. cerevisiae VPS13 (vps13-mut1:
L64K/I80E/L87E/I162R/L185E/A192E/L217R/V269E/L275D/M293K/L300R; Fig. 1B,
2B-C). In a second mutant, based on the assignment for residues 650-830 in C.
thermophilum VPS13, the alterations are in a band midway along VPS131-1390’s length
(vps13-mut2:
V690D/L692R/L694E/I715K/A717D/M720K/I722D/I761R/I768E/F790D/M796D/L798
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R/V802E/I816R/G820D/L827E; Fig. 2.1B, Fig. 2.2B). The mutations do not interfere
with folding as yeast VPS131-1350 constructs incorporating the mutations are monodisperse by negative stain electron microscopy, and the mutated constructs still bind
lipids (Fig. S2.1). Further, GFP-tagged full length wild-type and mutant constructs are
expressed in yeast and localize as expected (Lang et al., 2015) (Fig. 2.3A, S2.1).
Consistent with the bridge model, we found that the inability of diploid vps13α cells to
sporulate could only be rescued by introduction of plasmid-borne copies of VPS13, but
not of vps13-mut1 or vps13-mut2, even when expressed from high copy number (2 μm)
vectors (Fig. 2.3B).
We and others had previously speculated that VPS13 and related proteins like ATG2
could harbor channels to facilitate the transfer of lipids between membranes (Kumar et
al., 2018; Osawa et al., 2019; Valverde et al., 2019). Here we provide the first strong
evidence for a continuous, hydrophobic channel in VPS13, and by analogy in ATG2, and
a channel versus a shuttle lipid transfer mechanism. The size of the VPS13 lipid binding
cavity and, hence, ability of these proteins to accommodate many lipids simultaneously
suggests a role in bulk lipid transfer. Further, in the narrower, more C-terminal portions
of the channel, lipids will be lined up one behind the other, indicating directional
transport. Although the architecture of VPS131-1390 is distinct from that of other
eukaryotic lipid transport modules, it broadly resembles bacterial lipopolysaccharide
transporters, which feature a channel through which lipopolysaccharide travels from the
inner to the outer membrane of Gram-negative bacteria (Owens et al., 2019). The
bacterial channel also is a primarily ß-strand structure, though composed of multiple
small subunits, and resembles an open-ended basket. Importantly, it is associated with
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biosynthetic machinery in the inner membrane that pumps lipopolysaccharide into the
channel as it is produced, thus ensuring efficient, vectorial transfer. It is tempting to
speculate that this bridge-like transfer mechanism is conserved in eukaryotes, with
VPS13 and ATG2 similarly collaborating with the lipid biosynthetic machinery for
effective bulk lipid transfer.
The density map has been deposited in the EMD databank www.emdatabank.org/
(accession no. EMD-21113).

Materials and Methods
Protein expression and purification. Vps131-1390, comprising residues 1-1390 from C.
thermophilum Vps13, was cloned into a pCMV-10 vector containing an N-terminal
3XFLAG tag, and expressed using the Expi293 Expression System (Thermo Fisher
Scientific, Table S1). Cells were harvested after 95 hours and resuspended in lysis buffer
(50 mM HEPES, pH 7.8, 500 mM NaCl, 1 mM TCEP, and 5% glycerol supplemented
with EDTA-free protease inhibitor tablet (Roche)). Cells were lysed by sonication and
clarified via centrifugation at 27,216 g for 30 minutes. The protein was purified by batch
binding with anti-FLAG M2 Affinity Gel (Sigma). The resin was washed three times
with 5 bed volumes of lysis buffer. The washed resin was incubated overnight (about 15
hrs) with lysis buffer supplemented with 1 mM ATP and 2 mM MgCl2 in a total volume
of 10ml. The resin was washed three more times, with 10 bed volumes of lysis buffer and
eluted with 0.25mg/ml of 3X FLAG peptide (APExBIO). The eluted protein was loaded
onto a Superdex 200 10/300 column (GE Healthcare). The peak fractions were collected
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and concentrated by Amicon® Ultra-4 Centrifugal Filter Unit with 30 kDa MWCO.
Protein at a concentration of 0.3mg/ml was used for CryoEM sample preparation.
Cryo sample preparation and data collection (Table S2.2). For freezing EM grids,
freshly purified Vps131-1390 was supplemented with 0.02% n-Octyl-β-D-Glucoside. 4 ul
of sample was applied to Quantifoil R1.2/1.3 300 mesh copper grids after 30 s glow
discharge. Grids were plunge-frozen in liquid ethane using an FEI Vitrobot Mark IV
(Thermo Fisher Scientific) after blotting with a single blotting paper for 5 s at a blot force
of -2 in 90% humidity at 4°C. Data collection was performed using an FEI Titan Krios
G2 300 kV transmission electron microscope with K2 summit direct detection camera.
For the first dataset, 1976 micrographs were collected in super-resolution mode at a
magnification of 135,000k with 1.05Å/physical pixel with a total exposure of 8 s
fractionated into 40 frames for a total dose of 50.4 e-/Å2 with a defocus range of 1.9 m
to 2.8 m. For the second dataset, 970 micrographs were collected in super-resolution
mode at a magnification of 135,000k with 1.05Å/physical pixel and a total exposure of
6.2 s fractionated into 31 frames for a total dose of 49.5 e-/ Å2 with a defocus range of 1.4
m to 2.3 m.
Image processing (Fig. S2.2, Table S2.2). A total of 2946 micrographs from two datasets
was analyzed using RELION 3.0(Zivanov et al., 2018). Super-resolution micrograph
movie frames were binned by a factor of 2 and divided into 5x5 patches for motion
correction by MotionCor2 (Zheng et al., 2017). Contrast transfer function estimation was
done by CTFFIND-4 (Rohou and Grigorieff, 2015). Vps131-1390 forms tail-to-tail dimers.
Half of each dimer, corresponding to a monomer, was used for the 3D reconstruction. For
the first dataset, 1029 particles were manually picked from micrographs and subjected to
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2D classification (Fig. S2a). The two best 2D classes were used as references for autopicking in RELION 3.0 (Zivanov et al., 2018), which yielded a total of 564503 particles,
which were extracted using a box size of 250 x 250 pixels. For the second dataset,
506742 particles were auto-picked in RELION 3.0 (Zivanov et al., 2018) using the
refined 3D map from the initial dataset to generate 2D projections as references. Particles
were extracted using the same parameters as for the first dataset. For analyzing the first
dataset, several rounds of 2D classification with 200 classes were used to remove ice and
bad particles. An initial model was generated from 20,000 particles using stochastic
gradient descent with C1 symmetry. A total of 391,836 particles were then put into 3D
classification using the initial model as a reference. All the particles were classified into
either three or four classes, and the best classes from these two jobs were selected
separately. Particles that appeared in both classes were selected using a locally developed
script and polished using Bayesian polishing in RELION 3.0 (Zivanov et al., 2018). After
polishing and postprocessing, the resulting map, which was calculated from 61230
particles, had an estimated resolution of 4.23 Å. This map was used as a reference for 3D
classification for the second dataset. Following Bayesian polishing, the best final refined
map from the second dataset, based on 114134 particles, had a resolution of 3.9 Å.
Polished particles from the two final maps were pooled and subjected to per-particle CTF
refinement, as in (Wan et al., 2019; Yang et al., 2019), as implemented in RELION 3.0
(Zivanov et al., 2018). Final gold standard refinement and postprocessing were done with
the resulting 175,364 particles, producing a map with an estimated resolution of 3.75 Å
according to the FSC = 0.143 criterion. The map was sharpened during post-processing

43

with a B-factor of -105.771. Local resolution estimation was performed using the
RELION 3.0 (Zivanov et al., 2018) implementation.
The Vps131-335 crystal structure (6CBC) was docked into the map manually and fitted
using UCSF Chimera (Pettersen et al., 2004). The “pseudotrace” interpreting the map in
terms of secondary structure (in Fig. 2.1B) was built manually in Coot (Emsley et al.,
2010).
Sporulation assay: Diploid vps13Δ cells were transformed with plasmids (low copy
CEN/pRS413 or multi-copy 2μm/pRS423) GFP-tagged versions of VPS13, vps13-mut1
and vps13-mut2 under the control of the endogenous VPS13 promoter and transferred to
sporulation plates (Table S2.1). Sporulation efficiency was assessed by direct
visualization of ascospores by light microscopy after 1, 2, and 3 days of incubation at
30 °C. In these constructs, GFP was inserted after residue 499 of the VPS13 sequence,
where it is known not to interfere with VPS13 function (Lang et al., 2015). Residues in
the VPS13 channel were made hydrophilic in vps13-mut1
(L64K/I80E/L87E/I162R/L185E/A192E/L217R/V269E/L275D/M293K/L300R) and
vps13-mut2
(V690D/L692R/L694E/I715K/A717D/M720K/I722D/I761R/I768E/F790D/M796D/L798
R/V802E/I816R/G820D/L827E). Coding sequences for fragments of the genome
incorporating the mutations were purchased from Genscript and replaced the VPS13 WT
sequence in the mutant constructs.
Fluorescence microscopy: Yeast expressing GFP-VPS13 from a plasmid was cultured in
CSM-His media with 2% of glucose at 30°C. To assess the localization of GFP-VPS13
constructs, we used a wide-field DeltaVision microsope (Applied Precision/GE
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Healthcare) fitted with a 100x, 1.4 NA objective (Olympus) and solid-state laser
illumination. Images were acquired at 30°C using a CoolSnapHQ2 CCD camera
(Photometrics) and deconvolved using the iterative algorithm in softWoRx (7.0.0;
Applied Precision GE Healthcare).
Immunoprecipitation. Diploid vps13α cells were transformed with linearized integrating
plasmids (pRS406 backbone) expressing GFP-tagged versions of VPS13, VPS13-mut1,
VPS13-mut2 under the control of the GAL1 promoter using standard lithium acetate
transformation methods. Yeast colonies were then streaked on selection plates containing
2% galactose and GFP-expression and localization confirmed by microscopy. Selected
clones were grown in 100 ml of YP (1% Yeast Extract, 2% Peptone) media with 2%
Raffinose at 30°C. A final concentration of 2% galactose was added when the cultures
reached OD600 of 0.5. For each strain, 2 grams of wet yeast pellet was resuspended with
15 ml of buffer (50 mM NaCl, 50 mM HEPES, pH 7.4, 0.1% Tween-20, 1 mM EDTA, 1
mM PMSF) supplemented with EDTA-free protease inhibitor cocktail (Roche). Yeast
were lysed by vortexing with 5 g glass beads 20 times in 30-second pulses with 1-minute
rests on ice in between, and the lysates were clarified via centrifugation at 27,216 x g for
20 minutes. The protein was captured by batch binding with GFP-Trap Agarose
(Chromotek). The resin was washed three times with 5 bed volumes of buffer. The
washed resin was incubated with 6x Laemmli gel loading buffer at 95°C for 10 minutes
and proteins resolved on a 4% - 15% gradient native gel (Bio-Rad, #4568086).
Lipid-binding gel shift assay: 3XFLAG-tagged S. cerevisiae VPS131-1350 with WT or
mutant sequences were purified using the same strategy described above for C.
thermophilum Vps131-1390. For lipid binding, 7 ul of 150 nM purified protein was
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incubated with 1 mg of dried films of NBD-PA, NBD-PC, or no lipid on ice for two
hours. 7 ul of 2x native gel sample loading buffer were then added and 14 l of sample
was loaded onto a 4% - 15% gradient native gel (Bio-rad, #4568086) and run at a
constant voltage of 90V for 90 minutes.

Negative staining: 3XFLAG-tagged S. cerevisiae VPS131-1350 with WT or mutant
sequences were purified using the same strategy described above for C. thermophilum
Vps131-1390, while wild type VPS13 was purified from 50 ml of Expi293 cells and mutant
constructs 1 and 2 were purified from 200 ml of Expi293 cells. Samples were negatively
stained on copper grids overlaid with 10 nm amorphous carbon with 2% uranyl acetate.
Grids were imaged using an FEI Tecnai T12 microscope operated at an accelerating
voltage of 120 kV with a nominal magnification of 52,000x (2.14 Å/pixel at the specimen
level). 2D classification was performed in RELION 3.0.4, where 100 manually picked
particles were selected as references for Auto-pick in RELION 3.0.4. Final 2D
classification was done using auto-picked particles.
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Figure 2.1. VPS13 forms a channel for lipid transport. (A) The density map for VPS1311390 (contoured at 4.55 signal/noise), which resembles a twisted gathering basket. The
“basket” is colored light blue and yellow, where yellow corresponds to the portion of C.
thermophilum VPS13 previously crystallized (PDBID 6CBC, residues 1-335). Helices
comprising the “handle” are green, except for two helices from 6CBC (yellow). (B)
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Secondary structure is indicated. Red asterisks mark helices positionally adjusted with
respect to 6CBC to form part of the “handle”. For functional assays, mutations were
introduced to render bands within the VPS131-1390 channel hydrophilic and unable to
bind lipids. The bands are indicated in yellow (mutant 1) and blue (mutant 2) shading and
arrows. (C) Density map colored by local resolution. In a-c, VPS131-1390 in lower
panels is rotated by 90° with respect to the top panels. At top, the view is into the basket
interior at the VPS13 N-terminal end; in the bottom panels, the view is into the interior of
the basket at its C-terminal end. (See also Movie S1).
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Figure 2.2. The VPS131-335 fragment is located at the wider end of the VPS131-1390
“basket”. (A) VPS131-335 coordinates (PDBID 6CBC) were docked into the part of the
EM map colored yellow in Figure 1 A-B (top) and fitted (bottom). (B) VPS13 may
function as a channel for lipid transfer between membranes. Intact VPS13 resembles a
bubble wand(De et al., 2017); the portion corresponding to VPS131-1390 is blue.
Mutations were introduced to render the N-terminal or middle portion of the channel
hydrophilic, as indicated here and in Fig. 1B. VPS13 may cooperate with protein partners
to ensure directional lipid transport. (C) Changes in mutant 1 are indicated here in a
model of S. cerevisiae VPS13 based on the crystal structure of Vps131-335 (PDBID
6CBC):
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(L64K/I80E/L87E/I162R/L185E/A192E/L217R/V269E/L275D/M293K/L300R).
Mutations in
mutant 2:
V690D/L692R/L694E/I715K/A717D/M720K/I722D/I761R/I768E/F790D/M796D/L798
R/V802E/I816R/G820D/L827E.
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Figure 2.3. Mutations that render portions of the VPS131-1390 channel unable to bind
lipids (Fig. 2B-C) abrogate VPS13 function in sporulation. (A) Low copy (CEN/pRS413)
or multicopy (2μm/pRS423) plasmids encoding GFP-tagged VPS13 constructs were
expressed in vps13

strains and visualized as fluorescent punctae by fluorescence

microscopy. Also see Fig. S1. (B) Yeast lacking VPS13 fail to sporulate(Enyenihi and
Saunders, 2003). Sporulation can be rescued by VPS13 but not the channel mutants. The
experiment was repeated in triplicate. SD indicated.
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Supplementary Figure 2.1. Characterization of VPS13 mutant constructs. (A)
Immunoprecipitation of GFP-tagged VPS13 protein from yeast cells expressing the
protein from an integrated genomic copy under control of a GAL1 promoter. From left to
right: wild type, mutation 1, mutation 2. Proteins in each lane are purified from equal
numbers of cells, and the indicated yield is normalized to wild type VPS13 protein. (B)
Negative staining of 3xFLAG-tagged Saccharomyces cerevisiae VPS131-1350 purified
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from Expi293 cells, with representative 2D-class averages shown below. Numbers of
particles included in averages are indicated. from left to right: wild type, mutation 1,
mutation 2. (C) Lipid binding gel shift assay with Saccharomyces cerevisiae VPS1311350. Equal amounts of VPS131-1350 constructs are co-incubated with the indicated
fluorescent lipids (PA is phosphatidic acid; PC is phosphatidylcholine; NBD is
nitrobenzoxadiazole) or no lipids and separated on a native gel. Gel imaging performed
both by fluorescence imaging and Coomassie staining. From left to right: wild type,
mutation 1, mutation 2.
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Supplementary Figure 2.2. CryoEM workflow. (A) A representative raw micrograph of
Vps13 collected on a Titan Krios. Some of the particles are circled red. See Experimental
Methods for details. (B) CryoEM workflow resulting in a density map at 3.75 Å
resolution. The box side length of individual averages is 26.2 nm. See Experimental
Methods for details. (C) FSC curves after gold standard refinement for masked and
unmasked maps with FSC cut-off at 0.143 shown by a dashed line (D) CryoEM density
for selected high-resolution regions, consistent with the reported resolution range. (E)
Particle orientation distribution of the final map.
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Table S2.1 primer info

Construct
Species

Primer

VPS13

C.Thermo

cgaattcgagctcggcgcgccaatgttagaaggtctggtagcaggg

(1-1390)

philum

atatcagatctatcgatgaattcttacgtgtgctgctccacgtc

Name

gatatcgaattcctgcagcccggggaactgatcagtcctcgcaatattttc
"VPS13-

agactctaacatttaactgttcttaattttccttttttctg

mut1,

taagaacagttaaatgttagagtctttagctgctaatttg

VPS13-

cttgctcaccatatcttcattctcgtcaaattcaatag

mut2,

cgagaatgaagatatggtgagcaagggcgag

pRS413;

gtacaggacctttcttgtacagctcgtccatg

VPS13-

gagctgtacaagaaaggtcctgtactgcaag
S.

mut1,

tttcatatgtgatcataggatagcttcacagtac
Cerevisiae

VPS13-

agctatcctatgatcacatatgaaagtatatacccgc

mut2,

atcgtaaacgccgccgaggcaactgtagaaggttggacaacacaaacaagaatgggtatt

pRS423-

gagtctttgttggaagac

VPS13

accagaagagtaattaacgtaatcgccgttgttttcttcatcatcaatcatagaaggtatagaa
ttagcaatcaaattca
aaagctggagctccaccgcggtggctcaatctgggggtatgcg
aaagctggagctccaccgcggtggcatagcacgttcaacatccc

VPS13-

S.

actagtggatcccccgggctgcaggaattcatgttagagtctttagctg

mut1,

Cerevisiae

agcgtgacataactaattacatgactcgagtcataggatagcttcacag
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VPS13-

gcttatcgataccgtcgacctcgagatgttagagtctttagctg

mut2,

gacataactaattacatgactcgagtcataggatagcttcacag

pRS406-

cgaagagtaaaaaattgtacttggcg

GAL

aagacagaaaatttgctgacattg

Table S2.2. Cryo-EM data collection and image processing statistics

VPS131390 (EMD – 21113)
Magnification

13000x

Voltage (kV)

300

Electron exposure (e-/Å)

50.4 (Dataset 1)
49.6(Dataset 2)

Defocus range (m)

-1.9 to 2.9 m (Dataset 1)
-1.4 to -2.3 m (Dataset 2)

Pixel size (Å)

1.05 Å

Symmetry imposed

C1

Initial particle images (No.)

564503 (Dataset 1)
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506742 (Dataset 2)
Final particle images (No.)

175362

Map resolution (Å)

3.75

FSC threshold

0.143

Map resolution range (Å)

21 – 3.5

Map sharpening B factor (Å)

-105.771
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Summary
The phosphoinositide PI(3,5)P2, generated exclusively by the PIKfyve lipid kinase
complex, is key for lysosomal biology. Here we explore how PI(3,5)P2 levels within cells
are regulated. We find the PIKfyve complex comprises 5 copies of the scaffolding protein
Vac14, and one copy each of the lipid kinase PIKfyve, generating PI(3,5)P2 from PI3P,
and the lipid phosphatase Fig4, reversing the reaction. Fig4 is active as a lipid
phosphatase only in the ternary complex, whereas PIKfyve within the complex cannot
access membrane-incorporated phosphoinositides due to steric constraints. We find
further that the phosphoinositide-directed activities of both PIKfyve and Fig4 are
regulated by protein directed activities within the complex. PIKfyve autophosphorylation
represses its lipid kinase activity and stimulates Fig4 lipid phosphatase activity. Further,
Fig4 is also a protein phosphatase acting on PIKfyve to stimulate its lipid kinase activity,
explaining why catalytically active Fig4 is required for maximal PI(3,5)P2 production by
PIKfyve in vivo.

Eukaryotic cells have seven species of phosphoinositide lipids differentially enriched at
different compartments. Although these lipids are present only in minute quantities, they
play major roles in organelle dynamics and signaling. Two phosphoinositides critical for
lysosome biology are PI3P and its derivative PI(3,5)P2, which is generated by the still
poorly characterized PIKfyve complex (Hasegawa et al., 2017; Jin et al., 2016). PIKfyve
is conserved in all eukaryotes and is their only source of PI(3,5)P2. Highlighting the
importance of this complex in cell physiology, mutations in its subunits result in
disabling neurodegenerative diseases such as forms of Charcot-Marie Tooth (CMT)
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disease (Chow et al., 2007) and Amyotropic Lateral Sclerosis (ALS) (Chow et al., 2009).
PIKfyve inhibition has been proposed as an anti-viral treatment (Hulseberg et al., 2019;
Nelson et al., 2017), and a selective inhibitor of PIKfyve activity, apilimod, is being
evaluated as a treatment for non-Hodgkins lymphoma (Gayle et al., 2017).
In addition to the lipid kinase PIKfyve itself (also called Fab1), the complex includes a
lipid phosphatase in the Sac family, Fig4 (also called Sac3), and a scaffolding protein
Vac14 (also called ArPIKfyve) (Fig. 1A). While PIKfyve transfers a phosphate group
from ATP to convert PI3P to PI(3,5)P2, Fig4 dephosphorylates PI(3,5)P2 in the reverse
reaction.
How these activities are coordinated within the complex to avoid futile cycles of ATP
hydrolysis has been enigmatic. Further adding to the mystery is the observation that
PI(3,5)P2 levels in cells deficient in Fig4 activity, as for example in patients with CMT,
are reduced rather than upregulated as might have been expected (Chow et al., 2007;
Duex et al., 2006; Shisheva et al., 2019; Strunk et al., 2020).
Here we combine negative stain- and cryo-EM studies elucidating the architecture of the
human PIKfyve complex at medium to low resolution with a biochemical analysis to
obtain first insights as to how the antagonistic activities within the complex are regulated.
Our structural studies show that Vac14 pentamerizes into a star-shaped structure, which
can bind a single copy each of PIKfyve and Fig4. We have found that Fig4 is active as a
lipid phosphatase only in the intact complex including PIKfyve, whereas the ability of
PIKfyve to generate PI(3,5)P2 in membranes is suppressed in the complex as compared to
by itself.
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Our structural data indicate that complex formation conformationally restrains the kinase
domain to prevent its access to membranes containing the PI3P substrate. We further
report that in addition to its activity on lipid, Fig4 is a serine phosphatase that acts on
PIKfyve to increase its lipid kinase activity. While PIKfyve within the complex cannot
access PI3P, it may nevertheless be primed by Fig4 for maximal activity following a
conformational change, such as complex dissociation, in response to a still unknown
stimulus. This model would explain why the ablation of Fig4 activity depresses PI(3,5)P2
production in cells.

Vac14 forms a pentameric scaffold through which PIKfyve and Fig4 interact.

As a first step in understanding the regulation of the PIKfyve complex, we examined its
architecture and that of its subcomplexes by negative stain electron microscopy. The
protein assemblies were produced in mammalian cells (Expi293F) by transfecting these
with DNAs coding for one or combinations of PIKfyve components. Fig4 was Nterminally 3xFLAG-tagged to capture Fig4/Vac14 complex, PIKfyve was N-terminally
3xFLAG-tagged to capture PIKfyve alone or ternary complex, and Vac14 alone was
purified via an N-terminal 2xStrepII tag. Vac14, predicted to comprise almost entirely
alpha helical HEAT repeats, forms a rod that oligomerizes into a pentameric star-like
structure (Fig 3.1B). As C-terminal deletions abrogate Vac14 oligomerization (Ikonomov
et al., 2009), Vac14 self-association at the center of the star-shaped assembly must be via
its C-terminal portions. The N-terminus of Vac14 is at the other end of each Vac14 “leg”,
as identified by density corresponding to maltose binding protein (MBP) in 2D class
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averages of an MBP-Vac14 construct (Fig 3.1B). (We could not find density
corresponding to MBP in 2D class averages of a Vac14-MBP construct (distinct from the
MBP-Vac14 construct).) We next produced Fig4/Vac14, unexpectedly finding that only
one copy of Fig4 associates with each Vac14 pentamer. The density corresponding to
Fig4 appears between the N-terminal tips of two of the Vac14 “legs” (Fig 3.1C). PIKfyve
alone is elongated and kinked at one end (Fig 3.1D, top row). In the ternary complex,
there is density for a single copy of PIKfyve appended to one of the Vac14 legs that
flanks Fig4, extending away from the Vac14 pentamer (Fig 3.1E). We observed only a
single stoichiometry, a pentamer of Vac14 associated
with one copy each of the phosphatase and kinase, irrespective of the ratios of
Fig4:Vac14 or PIKfyve: Fig4:Vac14 DNAs used in transfection. Addition of
independently expressed and purified Fig4 and PIKfyve constructs did not change this
stoichiometry. The five-fold symmetry of the Vac14 pentamer is disrupted in both the
binary and ternary complexes, apparent as a different spacing between Vac14 legs
interacting with Fig4 and PIKfyve (Fig. 3.1F).

The Fig4 and PIKfyve active sites cannot access membranes simultaneously in

the complex.

A ternary complex comprising PIKfyveS2053E, which harbors a point-mutation in the
kinase activation loop (see characterization below), along with wildtype versions of Fig4
and Vac14 was analyzed further by cryo-EM, yielding a map at a final nominal resolution
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of 5.25 Å (FSC=0.143 criterion). Due to the extended shape and high flexibility of the
complex, it was not possible to obtain a single map with well-ordered density for all three
proteins. Rather, a reconstruction of the complete complex was synthesized from three
independent maps obtained from the same micrograph dataset, centered on different
portions of the complex, which were
calculated separately (as described in Methods; Fig. S3.1, S3.2) and superimposed based
on their overlaps, to form a composite reconstruction (Fig. 3.2). In the reconstruction, the
Vac14 pentamer is cup-shaped, measuring 240 Å across and 110 Å deep, with both Fig4
and PIKfyve occupying sites near the “rim” of the cup as defined by the Vac14 N
termini. Each Vac14 “leg” was modeled as a series of alpha helices, although their
connectivity could not be established at the resolution of the reconstruction. The Sac
homology module of Fig4 comprises an N-terminal regulatory and the upstream catalytic
domain and was modeled based on a crystal structure of the same module in Sac1 (PDB
4tu3). It could be confidently docked into density between opposite
surfaces of two neighboring copies of Vac14 (Fig. 3.2), corresponding to the highest
resolution region in our maps. The Fig4 active site is oriented to face the top of the Vac14
cup. The catalytic domain of the Fig4 Sac-homology module primarily mediates the
interactions with both neighboring Vac14’s. This interaction slightly twists one of the
Vac14 copies, likely modifying a surface on its opposite face to facilitate PIKfyve
binding, consistent with PIKfyve’s reported inability to bind Fig4 or Vac14 alone
(Ikonomov et al., 2009). We did not observe density that could be attributed to portions
of Fig4 downstream of its catalytic domain, although Fig4 C-terminal regions interact
with Vac14 (Ikonomov et al., 2009).
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PIKfyve comprises four structured regions, including a FYVE domain and CCR, CCT
and kinase modules, separated by long unstructured sequences (Fig 3.1A). We generated
homology models for the kinase and CCT modules of PIKfyve using threading software
(RaptorX and I-Tasser (Kallberg et al., 2012; Yang et al., 2015), PDB 1e8x and 3pn9).
The CCT module was manually fitted into PIKfyve density closest to Vac14 (Fig. 3.2B).
The CCT module consists of three domains, termed axial, intermediate and equatorial in
the chaperonin TCP1/TRiC where this module is also present, with the so-called
equatorial domain abutting Vac14. For the best fit into the map, the axial/intermediate
domains of PIKfyve were reoriented with respect to the equatorial domain as compared
to in other contexts (PDBIDs 1a6d, 5gw5, 3pn9). Consistent with our assignment, the
PIKfyve CCT-domain is required for the formation of the ternary complex (Botelho et
al., 2008; Ikonomov et al., 2009). The kinase domain was docked into the map adjacent
to the CCT-domain, with the kinase active site twisted by ~45° away from the top of the
Vac14 “cup” (Fig. 3.2B, C). As the resolution in this part of the map was low (local
resolutions are ~8-10 Å, Fig. S3.2D), locations of both the CCT and kinase domains were
independently confirmed by negative stain EM of MBP-labeled PIKfyve alone (Fig.
3.1D). In the cryo-EM maps, there is additional unassigned density in PIKfyve between
the CCT and kinase domains as well as adjacent to the kinase domain N-terminus. An
MBP-label inserted N-terminally to the CCR domain in PIKfyve is positioned between
the CCT and kinase domains in negative stain micrographs (Fig 3.1D), suggesting that
the density between the CCT and kinase modules in the cryo-EM maps corresponds to an
N-terminal portion of the CCR domain. The remaining unassigned density could
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correspond to C-terminal portions of the CCR region and/or portions or the FYVE
domain. The fold of the CCR module is unknown.
The PIKfyve complex is recruited to endo-lysosomal membranes via interactions
between PI3P and the FYVE domain of PIKfyve (Hasegawa et al., 2017; Jin et al., 2016).
Given the location of PIKfyve close to one of the Vac14 legs, it is plausible that the
complex associates with membranes via the “rim” of the Vac14 cup (Fig 3.2C). If the
complex is bound in this fashion, the Fig4 active site is oriented for optimal access to its
lipid substrate while the PIKfyve active site is rotated away from the membrane (Fig
3.2C) and so is sub-optimally positioned for contact with substrate. The different
orientations of their active site pockets in the complex indicates that either Fig4 or
PIKfyve, but not both, can access membrane bound phosphoinositides at one time.
This suggests a structural switching mechanism that controls the relative access of Fig4
and PIKfyve to substrate, and thus, their activities.

PI3P/PI35P2 metabolism by individual PIKfyve components is modulated within
the intact complex.
To better understand how lipid phosphorylation and dephosphorylation activities are
coordinated within the complex; we next compared these activities in subcomplexes,
containing either PIKfyve or Fig4/Vac14, and intact complex. To make the intact
complex for these experiments, we co-expressed Fig4 and Vac14, purified them together,
and then mixed the Fig4/Vac14 subcomplex with PIKfyve that had been expressed and
purified separately. We were unable to make Fig4 alone as it is proteolytically degraded
in the absence of Vac14, likely because its C-terminal portions are unstructured.
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We monitored PIKfyve lipid kinase activity on soluble diC6-PI3P (C6-C6-BODIPYFLPI3P)
as well as PI3P incorporated in liposomes, with different outcomes. We followed diC6PI3P conversion to diC6-PI(3,5)P2 by thin layer chromatography, finding that PIKfyve
alone and PIKfyve/Fig4/Vac14 phosphorylated diC6-PI3P with similar efficiencies (Fig.
3A). Although Fig4 in the intact complex dephosphorylates soluble PI(3,5)P2 (see below),
neither the presence of Fig4 or a catalytically inactivated version (C486S) significantly
affected PI(3,5)P2 generation. This could be because the PI3P phosphorylation reaction is
more efficient. In contrast, when we used a radiometric assay to monitor PI(3,5)P2
production from liposome incorporated PI3P and 32P-ATP, we found that only PIKfyve
alone but not PIKfyve/Fig4/Vac14 was active (Fig. 3.3B). This supports the notion that
the kinase domain cannot access PI3P in the membrane because of a conformational
restraint imposed within the complex, as suggested by the structure.
We next compared the lipid phosphatase activities of Fig4/Vac14 and
PIKfyve/Fig4/Vac14 on diC8-PI(3,5)P2 using the malachite green assay, which measures
the levels of orthophosphate released upon dephosphorylation. Robust Fig4 lipid
phosphatase activity was observed only in the intact complex, including PIKfyve (Fig.
3.3C). The conformational changes in Fig4/Vac14 induced when PIKfyve is added may
relieve an inhibition, perhaps by unblocking or rearranging the Fig4 active site. They may
also correctly orient the Fig4 active site with respect to the membrane, but such a
reorientation would not be necessary for activity with respect to the soluble diC8-lipids as
used in the assay.

70

The protein kinase and phosphatase activities of PIKfyve and Fig4 regulate

phosphoinositide metabolism.

PIKfyve has been well established as a ser kinase that auto phosphorylates itself to inhibit
its lipid kinase activity (Sbrissa et al., 2000). We found, unexpectedly, that PIKfyve
autophosphorylation is also required for the lipid phosphatase activity of Fig4 within the
complex, for only wild-type PIKfyve but not a catalytically inactive version (K1877E)
stimulates lipid hydrolysis by Fig4 in the malachite green assays (Fig. 3.3C). Because
PIKfyve and Fig4/Vac14 were prepared separately and then mixed in the absence of
ATP, it is improbable that Fig4 stimulation is due to its phosphorylation by PIKfyve.
Instead, it is PIKfyve autophosphorylation that must stimulate Fig4 activity.

To determine which sites in PIKfyve are auto phosphorylated and to obtain insights as to
how PIKfyve autophosphorylation might affect the activities of the complex with respect
to phosphoinositides, we prepared two versions of PIKfyve/Fig4/Vac14, one containing
wild-type and another the catalytically inactive PIKfyve (K1877E). We analyzed the
PIKfyve phosphosites by mass spectrometry (MS/MS), finding serines that were
phosphorylated only in the wild-type construct (S23, S48, S1522, S1669, S1969, and
S2053) (Fig. 3.4). One of these sites (S2053) was of particular interest as it is located in
the activation loop (residues 2036-2069) near the kinase active site, where it might play a
role in inhibiting kinase activity. Consistent with such a role, we found a ~2-fold
reduction in lipid kinase activity when we mutated this serine to glutamate, mimicking
phosphorylation, versus no reduction when the serine was changed to alanine (Fig. 3.3D).
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This reduction in activity is similar to that reported before for an auto phosphorylated
versus a dephosphorylated form of the kinase (Sbrissa et al., 2000). It is likely that
PIKfyve autophosphorylation at one or more of the six phosphosites we identified also
affects Fig4 lipid phosphatase activity.
The observations (1) that PIKfyve is both a lipid and a protein kinase whose
autophosphorylation affects both lipid kinase and phosphatase activities of the PIKfyve
complex (Sbrissa et al., 2000)(and above) and (2) that a catalytically active version of
Fig4 is required for normal PIKfyve function in vivo (Chow et al., 2007; Duex et al.,
2006; Shisheva et al., 2019; Strunk et al., 2020) prompted us to explore the possibility
that Fig4 might affect PIKfyve activity as a protein phosphatase. To determine whether
Fig4 might act on PIKfyve, we prepared two versions of the PIKfyve/Fig4/Vac14
complex, as described before, one containing wild-type and the other a catalytically
inactive Fig4 mutant (C486S). We again analyzed PIKfyve phosphosites in these
complexes by mass spectrometry, finding that three of the sites phosphorylated by
PIKfyve are dephosphorylated by Fig4 (S48, S1669, S2053). These sites include Ser2053
in the
PIKfyve activation loop, whose phosphorylation state affects lipid kinase activity (Fig
3.3D).
As another approach, we also overexpressed the two versions of the complex in
mammalian cells (Expi293F) and similarly analyzed PIKfyve phosphosites, with similar
results (S48 and S2053 are differentially phosphorylated). These results strongly support
the idea that in addition to acting as PI(3,5)P2 phosphatase, Fig4 is a serine phosphatase
that regulates PIKfyve lipid kinase activity, explaining why an active form of Fig4 is
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required for normal levels of PI(3,5)P2 in vivo. PTEN, the phosphatase that
dephosphorylates PI(3,4,5)P3 during PI3K/Akt signaling, also is active on protein
substrates (Myers et al., 1997), setting a precedent for phosphatases with dual specificity
on lipids and proteins.
Although relatively long, the PIKfyve activation loop cannot reach the Fig4 active site if
PIKfyve and Fig4 are placed as in the cryo-EM structure. It is plausible, though, that the
kinase and phosphatase active sites can move closer together as the complex flexes, or
that there are conformational changes that allow for closer proximity, or that PIKfyve and
Fig4 from different complexes interact in trans, or that Fig4 can act on PIKfyve either as
the complex assembles or disassembles. Conformational changes within the complex will
be subject to further investigation.

Concluding thoughts
The unusual 1:1:5 stoichiometry in the PIKfyve/Fig4/Vac14 complex is intriguing. From
our structural studies, a key role of Vac14 pentamerization is as a scaffold that
coordinates Fig4 and PIKfyve activities to avoid futile cycles of ATP hydrolysis. The
Vac14 scaffold helps to optimally orient Fig4 in the complex with respect to the
membrane for its lipid-targeted catalytic activities whereas PIKfyve is constrained and
unable to access membrane incorporated PI3P.
Still, there may be additional roles for Vac14 pentamerization. For example, the Vac14
pentamer could help define membrane micro zones that are enriched in either PI3P or
PI(3,5)P2, and these roles remain to be investigated. Our studies have also uncovered an
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exquisite interplay between the lipid-directed activities of PIKfyve and Fig4 and their
protein-directed activities that affect
phosphoinositide metabolism. We have found that PIKfyve autophosphorylation
downregulates its lipid kinase activities (as also reported in (Sbrissa et al., 2000)) while
simultaneously upregulating Fig4 activity with respect to phosphoinositide lipids. We
have also discovered a new role for Fig4 as a protein phosphatase required for PIKfyve
activation. Likely, PIKfyve and Fig4 will additionally be regulated by protein kinases and
phosphatases extrinsic to the complex, and this remains to be explored.
These studies represent a major advance in understanding the regulation within the
PIKfyve complex and lysosomal phosphoinositide homeostasis. Additionally, Vac14 has
been reported to interact with a host of proteins, including Rabs, RabGEFs, RabGAPs,
BAR domain proteins, scaffolding proteins, and others (Currinn et al., 2016; Ikonomov et
al., 2015; Jin et al., 2016; Malia et al., 2018; Mayer et al., 2018; Schulze et al., 2014),
which could modulate and be modulated by its interaction with the membrane and with
PIKfyve and Fig4. These interactions likely play a role in spatiotemporal regulation of
PIKfyve and Fig4 enzymatic activities, as well as signaling between the PIKfyve
complex and downstream effectors. The specifics of these interactions and their relation
to PIKfyve and Fig4 activities offer another clear avenue for follow-up work.

Materials and methods
Plasmid construction. Constructs of wildtype Vac14, Fig4, and PIKfyve were PCR
amplified from plasmids gifted by the laboratory of L.Weisman and cloned into indicated
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linearized plasmids using Gibson Assembly (NEB). Plasmids were linearized via BamH1
and Not1 restriction enzymes (NEB). StrepII-tagged Vac14 and His-tagged Fig4 were
cloned into pcDNA3.1 vector. 3xFLAG-Fig4 and -PIKfyve were cloned into pCMV-10
vector. The sequence for MBP was inserted into the vectors for PIKfyve or Vac14, as
indicated in Fig. 1A, using Gibson Assembly (NEB).

Protein expression and purification. For EM specimens, constructs encoding 3xFLAGPIKfyve(S2053E), His8-Fig4, and 2xStrepII-Vac14 were co-transfected into Expi293F
cells according to manufacturer instructions. Proteins were expressed for 48 hours after
transfection, then harvested by centrifugation and flash-frozen for storage or immediately
used for protein purification. Cells were lysed by 3 cycles of freezing and thawing in
buffer containing 100 mM HEPES, 700 mM NaCl, 0.5 mM TCEP, 1 mM ATP, 1 mM
MgCl2, and 1x EDTA-free protease inhibitor (Roche), pH 7.8. Insoluble debris was
removed by centrifugation at 15000 x g for 30 minutes. The supernatant was incubated
with anti-FLAG M2 beads (Sigma) for 2 hours, then
washed with 3 x 10 bed volumes of buffer and eluted in 3 x 0.5 bed volume of buffer
containing 0.25 mg/ml 3xFLAG peptide (APExBio). Elutions were immediately analyzed
by negative-stain electron microscopy to assess sample quality and concentration. Grids
were frozen immediately for cryoEM data collection.
For kinase and phosphatase enzymatic assays, constructs encoding 3xFLAG-tagged
versions of PIKfyve (WT, S2053E, S2053A, and K1877E) were transfected into Expi293
cells according to manufacturer instructions and expressed for 48 hours. For formation of
ternary complexes, 3xFLAG-Fig4 and 2xStrepII-Vac14 or 3xFLAGFig4(C486S) and
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2xStrepII-Vac14 were co-transfected into Expi cells for 48 hours. Cell pellets were
resuspended and lysed by freeze-thaw in buffer containing 100 mM HEPES, 500 mM
NaCl, 0.5 mM TCEP, 1x EDTA-free protease inhibitor (Roche), pH 7.8. After
centrifugation to remove insoluble material, supernatants were incubated with anti-FLAG
M2 beads, washed with 3 x 10 bed volumes of buffer, then incubated
overnight in 10 bed volumes buffer with 1 mM ATP and 1 mM MgCl2 added. Beads were
then washed again with 3 x 10 bed volumes of buffer, then eluted in 3 x 0.5 bed volume
of buffer containing 0.25 mg/ml 3xFLAG peptide.

Specimen preparation and imaging by negative stain EM. Indicated protein samples
were diluted to 50nM–100nM. 4ul of sample was loaded onto glow discharged copper
grids coated with 10nm of carbon film. Samples were negatively stained with 2% of
uranyl acetate and visualized on a FEI Tecnai T12 electron microscope operating at
voltage of 120kV with a nominal magnification of 52000x (2.14 Å/pixel at specimen
level). Images were further analyzed via RELION 3.0.4 (Zivanov et al., 2018) to obtain
2D class averages.

Cryo-EM specimen preparation and data collection (Table S1). Purified PIKfyve
complex samples were supplemented with 0.02% ß-octylglucoside immediately before
freezing and applied to Quantifoil Cu 300 mesh R1.2/1.3 grids glow discharged in
residual air for 30 seconds at 20 mA. Grids were then blotted and plunge-frozen in liquid
ethane cooled by liquid nitrogen using a Vitrobot Mark IV plunge-freezing robot (FEI)
(Fig. S1B).
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1913 movies were collected in super-resolution mode on an FEI Titan Krios at 300 kV
equipped with a Gatan K2 Summit direct electron detector, using a nominal
magnification of 130000x in super-resolution mode with a magnified pixel size of 1.05 Å
on the specimen level (counting mode). Movies were dose-fractionated into 40 frames of
0.2 seconds each at a dose rate of 1.6 e-/Å2/frame for a total dose of 64 e-/Å2. All
micrographs were collected with the stage tilted at a 30º angle to overcome a preferred
particle orientation bias.

Data processing (Fig. S1 and S2). Motion correction for 1913 micrographs was
performed in MotionCor2 (Zheng et al., 2017) with a binning factor of 2 and dividing
micrographs into 5x5 patches. Global CTF calculation was performed with CTFFIND4.1
(Rohou and Grigorieff, 2015). 954 particles were manually picked and subjected to 2D
reference-free classification in Relion 3.0.4 (Zivanov et al., 2018). Classes showing good
particle definition were chosen as references for automated particle picking in Relion,
yielding a dataset of 649,270 particles. Multiple rounds of 2D classification were used to
remove ice contamination and bad particles, leaving 218356 particles representing 21 2D
classes. These particles were used to generate
an initial model using the stochastic gradient descent algorithm as implemented in
Relion. The resulting reference model was used for 3D classification and refinement in
Relion. After Bayesian polishing, followed by further 3D classification, refinement, and
post-processing, a final model centered on the Vac14 pentamer, comprising 53279
particles with a resolution of 5.25 Å (FSC=0.143 criterion), was obtained. The density of
PIKfyve in the 5.25 Å map was diffuse and incomplete. To obtain a more complete map
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of the region around PIKfyve, particle subtraction was used in Relion to remove partial
density for Vac14 and Fig4 from the particles, after which 2D classification was
performed on the subtracted particles, yielding improved
alignment of the kinase region. Particle selection from these 2D classes was used to recenter the classes on the center of mass of the remaining density, closer to the kinase, and
these were used to auto-pick a new dataset, which was subjected to 2D classification,
initial modeling, 3D classification and refinement. This process of subtraction, recentering, auto-picking, and re-processing was repeated twice more before a dataset of
614008 particles, centered close to the kinase, which showed improved density after
modeling, was obtained. These were subjected to 2D classification with circular masking
to remove ice and bad particles, which yielded a good dataset of 39125 particles. Particles
from the best-defined 2D classes representing a range of different views were used for
initial modeling by stochastic gradient descent. This model was used for 3D classification
and refinement. After polishing and re-refinement, a model comprising 19998 particles
was used for multibody refinement to independently refine the kinase and the region
around Fig4 comprising two copies of Vac14, yielding maps of these regions with
nominal resolutions of 6.6 and 5.1 Å according to the FSC=0.143 criterion, respectively,
after
post-processing (Fig. S2B, C). Local resolution was estimated using the algorithm
implemented in RELION 3.0.4, and much of the map for the kinase domain is estimated
~8-10 Å resolution by this means (Fig. S2D). We attribute the discrepancy in part to the
inherent difficulty of measuring local resolution in cryoEM maps, which can vary
between algorithms. Importantly, this map exhibits well-defined tubular densities that
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closely match the helical arrangements of the CCT and kinase modules, and allowed
confident fitting of these modules, confirmed further by analysis of MBPtagged
constructs by negative-stain EM.
Homology models of Fig4 Sac homology and PIKfyve kinase modules were obtained
using RaptorX (Kallberg et al., 2012) against coordinates from PDB entries 4tu3 and
1e8x, respectively. The PIKfyve CCT domain was modeled using I-TASSER (Yang et
al., 2015) against coordinates from PDB entry 3p9e. For Fig4, models were rigid-body
fitted into the 5.1 Å cryoEM map, then manually adjusted in Coot (Emsley et al., 2010),
followed by real-space refinement in Phenix (Adams et al., 2010). The PIKfyve kinase
domain was rigid-body fitted into congruent density in the map of the kinase, then
manually adjusted in Coot and real-space refined in Phenix. The PIKfyve CCT was split
into separate models for the equatorial domain and the remainder of the module, which
were rigid-body fitted independently to allow for the domains to rotate relative to one
another. Vac14 helices were modeled de novo as poly-alanine into the 5.5 Å map using
Coot, but their connectivity could not be ascertained from the density, nor sequence
assigned.

Liposome preparation. For PIKfyve kinase enzymatic assays, substrate liposomes were
prepared by mixing lipid stocks dissolved in chloroform in glass test tubes in the
following molar ratio: 75% DOPC (Avanti Polar Lipids), 20% liver PE (Avanti Polar
Lipids), 5% PI3P diC16 (Echelon Biosciences). Lipid mixtures were evaporated to
dryness under a nitrogen stream, then dried further under vacuum for 30 minutes. Dried
lipid films were rehydrated under 1 ml buffer (100 mM HEPES pH 7.8, 500 mM NaCl,
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0.5 mM TCEP, 0.75 M sucrose) at 85 C for 30 minutes, then vortexed for 30 seconds to
generate crude liposomes. Liposomes were subjected to 7 freeze-thaw cycles to eliminate
multi-lamellar structures, then mixed with 2 volumes sucrose-free buffer and pelleted for
40 minutes at 16,000 x g. The resulting liposome pellet was resuspended in sucrose-free
buffer and pelleted again for 30 minutes. The second pellet was resuspended to 5 mM
total lipid concentration in sucrose-free buffer and used immediately.

Lipid kinase enzymatic assays—on liposome incorporated PI3P. Purified PIKfyve and
Fig4/Vac14 samples were analyzed by SDS-PAGE and Coomassie staining, then
quantitated by band densitometry against BSA standards. For complexes, PIKfyve WT or
K1877E samples were mixed in equimolar amounts with Fig4/Vac14 complexes. All
protein samples were diluted to a 100 nM final stock concentration (based on kinase
concentration). Shortly before preparing reactions, liposomes were swollen by pelleting
and resuspending in sucrose-free buffer containing 150 mM NaCl. Reaction mixtures
were prepared by combining protein (10 nM final concentration), sucrose-free buffer, a
10x ATP/Mg2+/Mn2+ solution (1 mM ATP, 20 mM MgCl2, and 5mM MnCl2 final
concentration), and 32P-ATP (2.5 uCi per reaction), then adding substrate liposomes to a
final concentration of 2.5 mM total lipid. Reactions were incubated at room temperature
for one hour, then removed to tubes containing EDTA (10 mM final) and proteinase K
(0.1 mg/ml final) and incubated for 15 minutes at room temperature. Liposomes were
then pelleted by centrifugation for 15 minutes at 16,000 x g. Pellets were resuspended in
100 l buffer, then transferred to scintillation vials for measurement of 32P radioactivity
in a scintillation counter.
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Lipid kinase enzymatic assay –on soluble PI3P lipids. For the assays on soluble diC6PI3P, the protein samples were diluted to 40nM final stock concentration (based on
PIKfyve quantitation). Shortly before preparing reactions, green fluorophore labeled C6C6-BODIPY-FL-PI3P (Echelon Biosciences) was dissolved in water to make a 50 M
stock solution. Reaction mixtures (20 l total volume) were prepared by combining
PIKfyve or the PIKfyve complex (10 nM final concentration) with diC6-PI3P (20 M
final concentration) in buffer (100 mM HEPES, pH 7.8, 150 mM NaCl, 0.5mM TCEP)
supplemented with 1 mM ATP, 2 mM MgCl2, and 0.5 mM MnCl2. The reactions were
incubated at room temperature for 1.5 hours and terminated by introducing ten volumes
of Chloroform:Methanol (1:2). The samples were dried by SpeedVac (ThermoFisher) at
35℃ for two hours, then dissolved in chloroform and separated by thin layer
chromatography as in (Taylor and Dixon, 2001). The phosphoinositide spots were
visualized under ultraviolet light and quantitated fluorometrically, using ImageJ.

Lipid phosphatase enzymatic assays. Purified PIKfyve was mixed with purified
Fig4/Vac14 complexes to achieve an equimolar ratio of PIKfyve to Fig4, with a final
concentration of 100 nM ternary complex. For Fig4/Vac14 only assays, Fig4/Vac14
complexes were directly diluted to 100 nM. Reactions were carried out in a 50 l volume
containing 50 nM protein complex, 50 M diC8 PI3P or PI(3,5)P2 (Echelon Biosciences),
and 2 mM MgCl2 for 1 hour at 37C. Released phosphate was quantitated using a
malachite green colorimetric assay in 96-well plate format according to the
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manufacturer’s instructions (Cayman Chemical #30412051), with measurements
performed on a BioTek Synergy H1M microplate reader.

PIKfyve phosphosite analysis by mass spectrometry. For in vitro
phosphorylation/dephosphorylation analysis, purified PIKfyve (WT or K1877E) and Fig4
(WT and C486S)/Vac14 complex samples were quantitated by band densitometry against
BSA standards after SDS-PAGE and Coomassie staining. PIKfyve WT or K1877E
samples were mixed in equimolar amounts with Fig4 (WT or C486S)/Vac14 complexes
to give four different combinations. Samples were incubated in the presence of 1 mM
ATP, 2 mM MgCl2, and 0.5 mM MnCl2 for 1 hour at room temperature. After incubation,
samples were resolved by SDS-PAGE and stained with Coomassie Brilliant Blue.
PIKfyve bands were excised from the gels after extensive washing in deionized water,
and submitted to the University of Alabama-Birmingham Proteomics core facility for
tryptic digestion and phosphopeptide identification by MS/MS. Samples of
PIKfyve/Fig4/Vac14 and PIKfyve/Fig4(C486S)/Vac14 complexes produced by cotransfection in Expi293 cells were similarly prepared and submitted for phosphosite
analysis at the University of Alabama-Birmingham Proteomics core facility.
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Figure 3.1. Assembly and gross architecture of the human PIKfyve complex by

negative stain EM analysis. (A) Domain organization of PIKfyve, Fig4, and Vac14. (B)
The Vac14 sample used for negative staining EM is pure as per SDS-PAGE. 2D class
averages of Vac14 or MBP-Vac14 show that it pentamerizes. Numbers of particles for
each class average are indicated. Maltose binding protein (MBP) fused to the Vac14 Nterminus is at the tip of the Vac14 “leg”. (C) The Fig4/Vac14 sample used for negative
staining EM is pure per SDS-PAGE. 2D class averages of Fig4/Vac14 show density for
Fig4 between two Vac14 “legs”. (D) Negative stain EM analysis of PIKfyve or
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MBP+PIKfyve fusions. MBP was inserted into the PIKfyve sequence as indicated by
arrows in 1A. The left-most column shows PIKfyve density from the cryo-EM maps (Fig.
2) with docked models of the CCT and kinase modules; the location of MBP in the class
averages is indicated as a grey ball. The other columns show 2D class averages of
PIKfyve by itself or with MBP-insertions. (E) The PIKfyve/Fig4/Vac14 sample used for
negative staining and cryo-EM is pure per SDS-PAGE. 2D class averages of
PIKfyve/Fig4/Vac14, showing that PIKfyve binds close to Fig4 at the tip of the Vac14
legs. (F) Schematic overlay of the Vac14 pentamers in Vac14, Fig4/Vac14, and
PIKfyve/Fig4/Vac14, showing that the 5-fold symmetry of the Vac14 pentamer is
distorted in the Fig4/Vac14 and PIKfyve/Fig4/Vac14 complexes.
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Figure 3.2. Cryo-EM reconstruction of the human PIKfyve complex at medium-low
resolution. (A) The composite reconstruction (see text and Methods) alone and with the
model. The left panels show the maps only, and the right panels also shows docked
protein models colored according to panel 1A. (B) Enlarged views showing the fit of the
Fig4 Sac homology module (top panels) and the PIKfyve CCT and kinase modules
(bottom panels) to the map. Two different views for Fig4 and PIKfyve are related by 90°
rotations. (C) Model for PIKfyve complex interacting with membrane. The Fig4 active
site is oriented to face the membrane, whereas the PIKfyve active site is twisted away
from the membrane by ~45° and so cannot access membrane incorporated
phosphoinositides.
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Figure 3.3. Complex formation affects the enzymatic activities of PIKfyve and Fig4
with respect to phosphoinositide lipids. (A) PIKfyve alone and in the
PIKfyve/Fig4/Vac14 complex phosphorylate soluble C6-C6-BODIPY-FL-PI3P with
similar efficiency, independent of whether the lipid phosphatase Fig4 is catalytically
active (WT) or not (C486S). (B) PIKfyve alone phosphorylates liposome incorporated
PI3P in a radiometric assay more efficiently that the PIKfyve/Fig4/Vac14 complex. A
plausible explanation is that the PIKfyve active site is sterically constrained in the
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complex and so unable to access membrane-incorporated PI3P. (C) In a malachite green
assay monitoring dephosphorylation of soluble di-C8 PI(3,5)P2, robust Fig4
lipid phosphatase activity was observed only for Fig4 in a complex with WT PIKfyve.
Complexes comprising a catalytically inactivated PIKfyve mutant (K1877E) were
significantly less active, and a binary complex lacking PIKfyve was the least active. (D)
PIKfyve lipid kinase activity is inhibited when Ser2053 in the kinase activation loop is
mutated to glutamate to mimic its phosphorylation but not when it is changed to alanine.
Experiments were carried out at least 3 times, as indicated. Significance determined by
Welch’s t-test.
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Figure 3.4. PIKfyve autophosphorylates itself, and Fig4 is also a protein
phosphatase that dephosphorylates PIKfyve. Samples of WT PIKfyve or a
catalytically inactivated mutant (K1877E) were mixed in equimolar amounts with Fig4
(WT or C486S)/Vac14 complexes to give four different combinations. Samples were
incubated in the presence of 1 mM ATP, then resolved by SDS-PAGE. The gels were
stained and the bands corresponding to PIKfyve were excised and submitted to the
University of Alabama-Birmingham Proteomics core facility for tryptic digestion and
phosphopeptide identification by MS/MS. Samples produced by co-expressing all three
proteins, including either WT or catalytically inactivated Fig4 (C486S), were
similarly prepared and submitted to the same core facility for PIKfyve phosphosite
analysis. Ser23, Ser28, Ser1522, Ser1669, Ser1969, and Ser2053 were phosphorylated in
complexes containing WT PIKfyve but not catalytically inactivated K1877E mutant.
PIKfyve lipid kinase activity is inhibited when Ser2053, in the kinase activation loop, is
mutated to glutamate to mimic its phosphorylation (in Fig. 3D). Importantly, Ser2053 is
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among sites that are dephosphorylated in complexes containing WT Fig4 but not a
catalytically inactivated (C486S) mutant. This suggests a model where Fig4 activates
PIKfyve by dephosphorylating PIKfyve’s activation loop Ser2053, explaining why
maximal PI(3,5)P2 production in vivo requires catalytically active Fig4.
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Figure S3.1: CryoEM work flow (part 1). (A) Cryo-EM work flow resulting in a map
centered on the Vac14 pentamer (map1) nominally at 5.25 Å resolution. (B)
Representative raw micrograph as collected on a FEI Titan Krios at 300 kV equipped
with a Gatan K2 Summit direct electron detector. Particles picked for initial 2D
classification are circled. See method section for more details. (C) FSC curves after gold
standard refinement for masked and unmasked map1 (centered on Vac14 pentamer). FSC
cutoff at 0.143 is shown by a dashed line. (D) Particle orientation distribution of map1.
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Figure S3.2: CryoEM work flow (part2). (A) Cryo-EM work flow, continued from
FigS1A, for maps centered on PIKfyve (map2, nominally at 6.6 Å resolution) and Fig4
(map3, nominally at 5.1 Å resolution). See method section for more details. (B) FSC
curves after gold standard refinement for masked and unmasked map2. (C) FSC curves
after gold standard refinement for masked and unmasked map3. (D) Maps colored by
local resolution. The discrepancy between the FSC=0.143 and local resolution estimate
for PIKfyve in map 2 is discussed in the Methods. Importantly, the map exhibits welldefined tubular densities that closely match the helical arrangements of the CCT and
kinase modules, and allowed confident fitting of these modules. The fitting was further
confirmed by analysis of MBP-tagged constructs by negative-stain EM. The inset shows
Vac14 helices placed into density from higher resolution portions of Map 1.

Table S3.1

Data collection and processing

Map1

Map2

Map3

Magnification

130000x

130000x

130000x

Voltage (kV)

300

300

300

Electron exposure (e–/Å2)

64

64

64

Defocus range (μm)

-1.5 to -3.5

-1.5 to -3.5

-1.5 to -3.5

Pixel size (Å)

1.05

1.05

1.05

Symmetry imposed

C1

C1

C1

Initial particle images (no.)

649270

614008

614008
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Final particle images (no.)

53279

19998

19998

Map resolution (Å)

5.25

6.6

5.1

FSC threshold

0.143

0.143

0.143

Table S3.2:

REAGENT or RESOURCE
SOURCE
Chemicals, Peptides, and Recombinant Proteins

IDENTIFIER

cOmplete™, EDTA-free

Roche Applied Science

Cat # 11873580001

APExBio

Cat # A6001

New England BioLabs

Cat # E2611S

Sigma Aldrich

Cat # A2220

Thermo Fisher

Cat # 28310

18:1 (Δ9-Cis) PC (DOPC)

Avanti Polar Lipids

Cat # 850375

16:0-18:1 PE

Avanti Polar Lipids

Cat # 850757

Protease Inhibitor Cocktail
3X (DYKDDDDK) Peptide
Critical Commercial Assays
Gibson Assembly® Master
Mix
ANTI-FLAG® M2 Affinity
Gel
Octyl-beta-Glucoside
Detergent

94

PI3P diC16

Echelon Biosciences

Cat # P-3016

PI(3,5)P2 diC16

Echelon Biosciences

Cat # P-3516

PI3P diC8

Echelon Biosciences

Cat # P-3008

PI(3,5)P2 diC8

Echelon Biosciences

Cat # P-3508

C6-C6-BODIPY-FL-PI3P

Echelon Biosciences

Cat # C-03F6

C6-C6-BODIPY-FL-PI(3,5)P2

Echelon Biosciences

Cat # C-35F6

Malachite Green Phosphate

Cayman Chemical

Cat # 10009325

This paper

EMD: 22634

Vac14 backbone models

This paper

PDB: 7K1Y

PIKfyve complex centered on

This paper

EMD: 22647

This paper

PDB: 7K2V

This paper

EMD: 22631

This paper

PDB: 7K1W

Gibco™ Thermo Fisher

Cat # A14527

Assay Kit
Deposited Data
PIKfyve complex centered on
Vac14 - map1

PIKfyve - map2
PIKfyve Kinase domain, CCT
domain models
PIKfyve complex centered on
Fig4 – map3
Fig4 Sac homology domain
model
Experimental Models: Cell Lines
Expi293F™ Cells
Oligonucleotides
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Primers for Recombinant

This paper

N/A

L. Weisman

N/A

This paper

N/A

This paper

N/A

This paper

N/A

This paper

N/A

This paper

N/A

This paper

N/A

This paper

N/A

This paper

N/A

This paper

N/A

DNA, see Table S2
Recombinant DNA
Construct of wildtype Vac14,
Fig4, PIKfyve
Plasmid: pcDNA3.1 2xStrepII-tagged Vac14
Plasmid: pcDNA3.1 2xStrepII-tagged Vac14 - MBP
Plasmid: pcDNA3.1 - Histagged Fig4 -WT
Plasmid: pcDNA3.1 - Histagged Fig4 -CS
Plasmid: pCMV-10 3xFLAG-Fig4 - WT
Plasmid: pCMV-10 3xFLAG-Fig4 - CS
Plasmid: pCMV-10 3xFLAG-PIKfyve - WT
Plasmid: pCMV-10 3xFLAG-PIKfyve – S2053E
Plasmid: pCMV-10 3xFLAG-PIKfyve – S2053A
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Plasmid: pCMV-10 -

This paper

N/A

This paper

N/A

This paper

N/A

This paper

N/A

ImageJ

Schneider et al., 2012

https://imagej.nih.gov/ij/

RELION 3.0.4

Zivanov et al., 2018

DOI: 10.7554/eLife.42166

RaptorX

Kallberg et al., 2012

http://raptorx.uchicago.ed

3xFLAG-PIKfyve – K1877E
Plasmid: pCMV-10 3xFLAG-PIKfyve – 722MBP-723
Plasmid: pCMV-10 3xFLAG-PIKfyve – 1192MBP-1193
Plasmid: pCMV-10 3xFLAG-PIKfyve – 1806MBP-1807
Software and Algorithms

u/
I-TASSER

Yang et al., 2015

https://zhanglab.ccmb.me
d.umich.edu/I-TASSER/

Other
Quantifoil®, Orthogonal Array

TED PELLA, INC

of 1.2µm Diameter Holes 1.3µm Separation, mounted on
a 300M Cu grid
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Cat # 658-300-Cu

Table S3.3: Recombinant DNA and primers:
2xStrepII-tagged Vac14
ATATAGATCTATGAACCCCGAGAAGGATTTCG
ATATGCGGCCGCTCATCAGAGGACAACCCTCCGG
2xStrepII-tagged Vac14 - MBP
ACGATGACAAGCTTGCGGCCGCAAACCCCGAGAAGGATTTCG
TCGATTTTGAGGACAACCCTCCGGTC
GGTTGTCCTCAAAATCGAAGAAGGTAAACTGG
AGGGATGCCACCCGGGATCCTTAAGTCTGCGCGTCTTTCAG
His-tagged Fig4 -WT
ATATGTCGACATGCCCACGGCCGCCG
ATATCTCGAGCAGGTAGCGGTTCCTGATGTACTC
His-tagged Fig4 -CS
GCATCCTTCGAACCAACAGTGTGGACTGTTTAGAT
ATCTAAACAGTCCACACTGTTGGTTCGAAGGATGC
3xFLAG-PIKfyve - WT
ATATGTCGACATGGCCACAGATGATAAGACGTC
ATATGCGGCCGCTCAGCAATTCAGACCCAAGCCTGTC
3xFLAG-PIKfyve – S2053E
TGGGACAAAAAGCTTGAGATGGTTGTGAAAGAGACAGGAATTTTAGGTGG
AC
GTCCACCTAAAATTCCTGTCTCTTTCACAACCATCTCAAGCTTTTTGTCCCA
3xFLAG-PIKfyve – S2053A
GACAAAAAGCTTGAGATGGTTGTGAAAGCAACAGGAATTTTAGG
CCTAAAATTCCTGTTGCTTTCACAACCATCTCAAGCTTTTTGTC
3xFLAG-PIKfyve – K1877E
98

GCGGGAGAGTTTCATGAGATGCGTGAAGTGATTC
GAATCACTTCACGCATCTCATGAAACTCTCCCGC
3xFLAG-PIKfyve – 722-MBP-723
CGCGCAGACTTGCATTGATCCTATTGTGCTTCAG
CTTCGATTTTAGTAAACTTAGTTTCTTCTCTGTAGAG
TAAGTTTACTAAAATCGAAGAAGGTAAACTGGTAATCTGGATTAACG
GATCAATGCAAGTCTGCGCGTCTTTCAGGGCTT
3xFLAG-PIKfyve – 1192-MBP-1193
CGCGCAGACTGAGAGAGGGCTTATTCTGAG
CTTCGATTTTTTCATCACCCTCATTTTTGC
GGGTGATGAAAAAATCGAAGAAGGTAAACTGG
GCCCTCTCTCAGTCTGCGCGTCTTTCAG
3xFLAG-PIKfyve – 1806-MBP-1807
CGCGCAGACTCCTCATGTGGAACTTCAATTTTC
CTTCGATTTTATTTATGAGTTGCTTCTTTTGTG
ACTCATAAATAAAATCGAAGAAGGTAAACTGG
CCACATGAGGAGTCTGCGCGTCTTTCAG
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Chapter 4 Investigation of VPS13 interaction with acceptor
membrane
LTP localization at MCS aids in the selective and directional transfer of lipids. Lipids are
first extracted from the donor membrane, then transferred across the cytosolic space, and
finally inserted into the acceptor membrane. As a soluble protein without transmembrane
region, VPS13 likely interacts with additional protein machinery at both membranes to
perform the extraction and insertion step. To better understand these processes, the nature
of the interactions between VPS13 and these proteins must be characterized. Several
domains and motifs are found to mediate the interaction of VPS13 with membranes in
humans. An FFAT motif at loops in the N-terminal halves of VPS13A and VPS13C
tethers the protein to the ER by interacting with the ER-resident VAMP-associated
protein (VAP). The WD40-like domain at the C-terminal end drives VPS13C localization
to endolysosomal membranes (Kumar et al., 2018). Additionally, the C-terminal PH-DH
domain recruits VPS13A to mitochondria, while this domain in VPS13A and VPS13C
recruits them to lipid droplets (Kumar et al., 2018). The slight sequence variations in
these conserved domains may contribute to the specific localization patterns of the
VPS13 isoforms to different contact sites. In yeast, Mcp1, Ypt35, and Spo71 have been
identified as proteins responsible for recruiting VPS13 to mitochondria, the endosome, or
the prospore membrane, respectively. The three proteins use a similar PxP motif to
interact with the WD40-like domain of VPS13. The three proteins competitively recruit
VPS13 to different contact sites by varying their expression levels (Bean et al., 2018).
The WD40-like domain in VPS13 is reminiscent of another WD40 protein, WIPI4, which
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is an interacting partner of ATG2 in humans. ATG2 is recruited to autophagosomes by
interacting with WIPI4, which interacts with PI3P localized on autophagosome. It is
intriguing to speculate that VPS13, when functioning alone, might mimic the function of
an ATG2-WIPI4 complex. It is also possible that the VPS13 WD40 domain may play a
direct role in lipid transfer to the acceptor organelle membrane. To better understand how
VPS13 MCS localization is regulated by interaction with protein partners at different
acceptor organelles, I decided to study the structure of the VPS13’s WD40 domain and
how it binds to the PxP motif.

Chapter 4.1 Identification of soluble VPS13’s WD40 domain fragment

VPS13 contains an N-terminal lipid transfer domain followed by a WD40 domain and a
DH-PH domain at the C-terminus (Figure 4.1). However, the exact boundaries of the
WD40 domain are unknown. As the first step in studying the WD40 domain of VPS13, I
designed a series of fragments with various N- and C-terminal boundaries and tested their
ability to fold well using an E. coli expression system. From the 22 constructs that I
designed and expressed, I hoped to find a soluble, well-behaved fragment that includes
the entire WD40 domain. The list of fragments can be found in Supplemental Table 4.1.
Six out of the 22 constructs expressed well. I picked the longest soluble fragment, and
trimmed its boundaries further to generate a final construct consisting of VPS13 residues
1944–2635, which has a size of 79kDa. I tried both N- and C-terminally 6xHis tagged
fragments, and found that the C-terminally tagged variant had comparatively fewer
degradation products upon purifying the proteins under similar conditions, therefore more
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selectively enriching for the complete fragment during affinity binding. The construct ran
as a monodisperse peak at around 15ml from Superdex 200 10/300 size exclusion
chromatography (Figure 4.1). It ran as a single protein band around 79kDa determined by
SDS gel electrophoresis. An aliquot from the peak fraction was imaged using negative
stain electron microscopy (EM), which revealed that the WD40 domain folded into a
semi-circle shape (Figure 4.3), similar to the structural feature also present in full length
VPS13 that was also imaged using negative stain EM (De et al., 2017).
Apart from the WD40 domain, I designed several fragments comprising the PH-DH
domain and tested their expression in E. coli. The constructs I made and tested by E. coli
expression are also indicated in Supplemental Table 4.1. However, none of them behaved
well upon purification from E. coli. I reasoned that it is because some binding partners, or
other regions of VPS13, might be required for the fragments containing this domain to
fold properly in vitro.

Chapter 4.2 PxP motif interacts with C-terminus of VPS13’s WD40 domain

To future investigate the interaction between the WD40 domain of VPS13 and the PxP
motif, a copy of the PxP motif from Mcp1 (about 10 amino acids long) was fused to the
N-terminus of the WD40 domain linked by five amino acids (details can be found in the
Materials and Methods section). The chimeric construct behaved well in E. coli, and its
yield was comparable to that of WD40 domain alone. Interestingly, the peak of the
WD40 domain that contained an N-terminally fused PxP motif shifted 2ml to the left in
Superdex 200 10/300 size exclusion chromatography (Figure 4.2), suggesting an increase
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in size compared with WD40 domain alone. Negative stain EM of this WD40 domain
with N-terminally fused PxP motif showed monodisperse particles, and 2D class
averaging revealed a ring composed of a dimer of semi-circles (Figure 4.3). In another
scenario, the PxP motif was fused to the C-terminus of the WD40 domain via a six amino
acid linker. At similar expression and purification conditions, the yield of WD40–PxP is
three times that of WD40 domain only, suggesting that the fragment with the PxP motif
fused on the C-terminus is comparatively more stable. However, negative stain EM 2D
class averages of WD40 with C-terminally fused PxP motif indicates a monomeric semicircle (Figure 4.3). Overall, the results above suggest that the PxP motif interacts with the
C-terminus of VPS13’s WD40 domain.

Chapter 4.3 Crystallization of VPS13’s WD40 domain

To study the structure of VPS13’s WD40 domain, I chose x-ray crystallography as the
primary method. Crystal Screen, Index, PEGRx screen (Hampton), Wizard Classic
Crystallization Screen (Rigaku) and JCSG+ Suite (Qiagen) were used to hunt for initial
“hits.” Among the three constructs, the WD40 monomer failed to generate any initial
crystal “hits,” and the PxP-WD40 dimer gave rise to 48 crystal “hits” from initial screens.
A list of crystallization conditions that gave rise to crystal “hits” can be found in
Supplemental Table 4.2. In order to optimize crystallization conditions, a customized
crystallization screen was designed based on the information from the initial 48 crystal
“hits”; the specific conditions are detailed in Supplemental Table 3. Half of the drops
from the customized screen grew initial hits, and four of them were promising 3D
106

crystals. Continuing from the four conditions, finally, two of the conditions gave rise to
crystals that diffracted to 3.5 Å using the home x-ray generator at the Yale Medical
School (Figure 4.4). (For details on crystallization conditions and x-ray generator settings
used for exposing the crystals, see the Materials and Methods section and Supplemental
Table 4.3.) The crystals that diffracted well were highly dependent on the freshness and
concentration of the protein. The method for determining the concentration of the protein
is described in Materials and Methods section.

Chapter 4.4 Solving the phase problem for the structure of VPS13’s WD40 domain

I took two approaches in parallel in order to solve the phase problem for the crystal
structure of the VPS13’s WD40 domain. I initially planned to take advantage of the
anomalous dispersion signal from heavy metals incorporated in the crystals for phasing.
The heavy metal must bind the protein specifically and can either be soaked into a preexisting crystal or co-crystallized with the protein. In order to test the heavy metal
binding properties of the VPS13’s WD40 domain, I set up a heavy metal binding screen
where I incubated purified protein with a series of heavy metal solutions. I found out that
the WD40 domain can bind with gold, mercury, cadmium and lead compounds (Figure
4.5 and Figure 4.6). The result provides several options for heavy metal soaking or cocrystallization. I tried to co-crystallize the protein with either gold or mercury, but was
not able to grow a well-diffracting crystal.
The second approach I took for solving the phase problem was by crystallizing
selenomethionine-substituted protein. After recently fine-tuning the expression conditions
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based on our lab’s protocols, I managed to produce milligram quantities of
selenomethionine-substituted protein. The protein is well-folded as a dimer when
assessed by negative staining EM. To obtain a high-quality crystal, I tried using similar
crystallization conditions as the native protein, as well as optimizing crystal growth by
varying the protein concentration, buffer conditions, temperature, well solution
composition, the volume of the drop, as well as micro-seeding, but I was only able to
grow crystals that diffract to 7 Å. To optimize the protein fold, I designed two constructs
that deleted two different loops (loop1: 2316-2338; loop2: 1964-1976) from the original
WD40 domain, but none of them yielded well-behaved protein. Compared to native
protein, selenomethionine-substituted protein is less soluble, as it can only be
concentrated to two-thirds of the highest concentration of native WD40 domain, and
crystals appear in two days in comparison to the 10 days required for native protein
crystal formation. From these findings, I believe that slowing down crystal growth of
selenomethionine-substituted protein will help with the ordering of crystal.
Another avenue for structure determination might be cryo-EM. If the molecule is too
flexible to obtain an atomic resolution structure by cryo-EM, a combination of cryo-EM
and x-ray crystallography can be used, where a lower resolution version of the structure
from cryo-EM could be used as a search model for molecular replacement. However,
after testing four different freezing conditions, I have not yet found freezing conditions in
order to obtain good cryo grids (Supplemental table 4.4). Ice on the four grids was too
thick to acquire a good signal for the protein particles. Lowering the glycerol
concentration in final protein might help with ice thickness on the grids.
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Materials and Methods
Plasmid construction. Constructs of wildtype VPS13’s WD40 domain were PCR
amplified from C. thermophilum genomic DNA and cloned into pET-Duet plasmids
containing a uncleavable N- or C-terminal 6xHis tag using T4 ligase. Constructs of
wildtype VPS13 PH-DH domain were PCR amplified from C. thermophilum genomic
DNA and cloned into pCDF vector containing a uncleavable N- GST tag using T4 ligase.
Plasmids and insert were linearized via BamH1 and Not1 restriction enzymes (NEB).
Loop deletion constructs were generated using Q5® Site-Directed Mutagenesis Kit
(NEB).

Construct information for C. thermophilum VPS13 PxP-linker-WD40-6xHis
Backbone: Pet-Duet. (Ampicillin resistance; F primer: pet-up; R primer: duet-down)
Sequence of insert:
MVSLVELDPAPIA(PxPmotif)EDAVVD(linker)APYRIRNYTGFDVIISTKRQIPGASP
TTEQQLPTMTLRLEDGQEAPWSFEEWEKMRESLMTESSTANSISVQLVGSGFQE
VKSIRLTREGEFLFGLKPKTQQVLHKLLVEIKLGKDNIKYVTLRSPLLVENDTGIV
VELGVYDAHEGHLLKIERINPGESKPAPVGAAYFKSLLVRPDPGFKYGWSSDTL
WWRDLLKRPTKTLVCKSEQYGGEVFYFRLHARWDQANPLTRNYPYMRLKLTA
PLTIENLLPYDFKYKIYDRVNKQEWNNFLRKGGSIPVHMVDLSHTFLLGIEMQDT
PFQASEFVVINTGNADDFKKDSHLVVKDNAGMPLNLRLHYFRIPDGGGSFKVTV
YSPYVILNKTGLDVSVRSKGFMQSARAAAGQTLIDVGGDGQKKARPLMFSFHN
DDHRNRALLKAGDSEWSKPQSFDAIGSTTEVVLQTANRNAEIHLGVTVDSGQGK
YKMVKVVTLAPRYVIHKLGEDINIREPSSSFWIPLKHGAHRPLHWLQRGAVKQL
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CLCYPGVDNQWTAPFNISDLGITHLKIARAGQRQRLIRVEILMEDATIFLNLSMEQ
RNWPFSMRNESDTEFTFYQVNPTIEEDASEDRSGWRPVRYRLPPRSIMPYAWDFP
AAKHKEICICAYNKERHVKLQEIGNLMPMKLALPNGESKTIDINVTADGPTQTLI
LSNYRQSKSLYRQ(CT-VPS13-1944-2635)HHHHHH(6 x His tag without linker)

Expression and purification of native VPS13’s WD40 protein C-terminally tagged
VPS13’s WD40 domain was expressed in BL21(DE3) codon plus cells (Agilent). Cells
were grown in LB media supplemented with antibiotic at 37℃ to an OD of 0.6. Protein
expression was induced by 0.5mM of isopropyl β-D-1-thiogalactopyranoside (IPTG) and
incubated at 18℃ for 20hrs. Cells were pelleted and resuspend using lysis buffer (NaCl
500ml, HEPES 20mM: pH 7.8, Imidazole 20mM, TCEP 1mM, Glycerol 10%)
supplemented with 1mM of PMSF (Phenyl Methyl Sulfonyl Fluoride). Cells were lysed
with an Emulsiflex-C5 cell disruptor (Avestin). Cell lysate was clarified via
centrifugation. The protein was purified using affinity chromatography with Ni-NTA
resin (Qiagen). After washing three times with 10 x bed volume of lysis buffer, protein
was eluted using lysis buffer supplemented with 500mM imidazole. The elution was then
purified using Superdex 200 10/60 column (GE Healthcare) equilibrated with FPLC
buffer (NaCl 500ml, HEPES 20mM: pH 7.8, Tcep 1mM, Glycerol 10%). Peak fractions
were concentrated using Amicon Ultra 4 with cut-off of 100kDa.

Expression of selenomethionine-substituted protein Selenomethionine-substituted
protein expression was modified from methods described previously (Doublie, 1997). To
summarize, an overnight LB culture was inoculated into 1L of 1xM9 media
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supplemented with 0.2% glucose, 2mM Mg2SO4, 0.1mM CaCl2, 0.1mM thiamine, and
antibiotic. Cells were grown at 37°C until the OD600 reached 0.5. 100mg each of
threonine, lysine, phenylalanine; 50mg of leucine, isoleucine, valine; and 120mg of DLseleno-methionine were added per 1 liter of cell culture. Cells were shaken at 30°C for
1hr to deplete methionine. Protein was induced by 0.5mM of IPTG and overexpressed at
18°C for 20hrs. Selenomethionine-substituted protein was purified using the same
strategy as native protein.

Protein crystallization trays WD40 dimer protein was concentrated to a final
concentration of 3mg/ml. (The concentration was measured using Bradford assay.
Calculation is based on a standard curve: (reads – 0.095) / 0.06943 * 20 / load(l) = Con
(mg/ml). For example, for 4ul of protein solution into 1ml of 1x Bradford solution,
normally the reads are around 0.5 – 0.52, meaning the final concentration is around
3mg/ml). The Formulatrix NT8 liquid handling robot was used for setting up 96-well
crystallization screen, where the settings were for 100nl of protein mixed with 100nl of
mother liquor. The mixture was equilibrated using 50l of mother liquor with 500mM of
NaCl in an Intelli low-profile plate (Hampton). For well-diffracting crystals of the native
protein, 2l of protein was mixed with 2l of 100mM imidazole, pH 8.0 and 80mM
Li2SO4 (mother liquor A). The mixture was equilibrated using 500l of mother liquor A
with 55l of 5M NaCl. In another case, 2l of 3mg/ml native protein was mixed with 2l
of 90mM imidazole, pH 8.0 and 50mM Li2SO4 (mother liquor B). The mixture was
equilibrated using 500l of mother liquor B with 55l of 5M NaCl in 24 well
crystallization plate (Hampton M plate). In both cases, crystals appeared after 10 days.
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Crystals were mounted in a 0.1-0.2um cryo-loop and dipped serially in mother liquor A/B
supplemented with 5% glycerol, 10% glycerol, 15% glycerol and then 20% glycerol. The
loops were then mounted, with the crystals centered onto an AFC 4-axis goniometer.
Crystals were protected using Oxford Cobra cryo-stream and exposed to Rigaku X-ray
Generator for 300s, and the diffraction data was collected with a Dectris Pilatus 200K
Pixel Array Detector (Rigaku) in the Macromolecular X-Ray Crystallography Core at the
Yale Medical School.
Heavy metal binding and gel shift assay For heavy metal screening, 4l of purified Cterminal 6xHis tagged PxP-WD40 protein at 1mg/ml was mixed with 4l of the heavy
metal stock solutions (Hampton) listed with their concentrations in Figure 4.5 and 4.6.
Concentrations used for heavy metal solutions are indicated. If the concentrations of
heavy metal solutions are higher than the indicated concentrations, the protein will
precipitate out upon mixing. The mixtures were kept on ice for 30 minutes. 8l of native
gel loading buffer was then mixed with protein and heavy metal before loading onto a
native gel. 15l of the final mixture was loaded onto a 4% - 15% gradient gel (Bio-Rad).
The native gel was run at a constant voltage of 100V for 100mins at 4℃.

Supplemental Table 4.1 Construct boundary information for VPS13’s WD40 domain.
Well-behaved constructs are bolded.
Constructs

domain

C. thermophilum VPS13 1626 – 2638

WD40

C. thermophilum VPS13 1807 – 2638

WD40

C. thermophilum VPS13 1940 – 2638

WD40

112

C. thermophilum VPS13 2040 – 2638

WD40

C. thermophilum VPS13 1807 – 2798

WD40

C. thermophilum VPS13 1940 – 2502

WD40

C. thermophilum VPS13 1940 – 2533

WD40

C. thermophilum VPS13 1940 – 2571

WD40

C. thermophilum VPS13 1940 – 2605

WD40

C. thermophilum VPS13 1977 – 2502

WD40

C. thermophilum VPS13 1977 – 2533

WD40

C. thermophilum VPS13 1977 – 2571

WD40

C. thermophilum VPS13 1977 – 2605

WD40

C. thermophilum VPS13 2007 – 2502

WD40

C. thermophilum VPS13 2007 – 2533

WD40

C. thermophilum VPS13 2007 – 2571

WD40

C. thermophilum VPS13 2007 – 2605

WD40

C. thermophilum VPS13 2042 – 2502

WD40

C. thermophilum VPS13 2042 – 2533

WD40

C. thermophilum VPS13 2042 – 2571

WD40

C. thermophilum VPS13 2042 – 2605

WD40

C. thermophilum VPS13 2649 – 3225

PH-DH-PH

C. thermophilum VPS13 2649 – 3087

PH-DH

C. thermophilum VPS13 2811- 3225

DH-PH

C. thermophilum VPS13 2811 – 3087

DH
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Supplemental Table 4.2. Crystallization conditions for initial “hits” of WD40 dimer;
conditions for 2D or 3D crystals are bolded.
Number

Buffer

Salt

Precipitant

0.1 M Sodium acetate

10% w/v Polyethylene

trihydrate pH 4.0

glycol 4,000

0.1 M MES

14% w/v Polyethylene

monohydrate pH 6.0,

glycol 4,000

1

2

0.1 M Sodium citrate
3

0.1 M Lithium sulfate

20% w/v Polyethylene

monohydrate,

glycol 1,000

tribasic dihydrate pH
5.5
2% v/v Tacsimate pH
0.1 M Imidazole pH

4

8% w/v Polyethylene
7.0, 5% v/v 2-

7.0

glycol 3,350
Propanol

0.1 M MES

0.4 M Sodium

0.5% w/v Polyethylene

monohydrate pH 6.0,

malonate pH 6.0

glycol 10,000

5

0.2 M Potassium
0.1 M BIS-TRIS pH
6

10% w/v Polyethylene
sodium tartrate

6.5

glycol 10,000
tetrahydrate,

100 mM Potassium
phosphate monobasic/
7

10% (w/v) PEG 3000
Sodium phosphate
dibasic pH 6.2
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100 mM Imidazole/
1000 mM Ammonium
8

Hydrochloric acid pH
phosphate dibasic
8.0
100 mM Tris base/

9

Hydrochloric acid pH

20% (w/v) PEG 1000

8.5
100 mM HEPES/
10

Sodium hydroxide pH

30% (v/v) PEG 400

7.5

11

100 mM HEPES/

200 mM Sodium

Sodium hydroxide pH

chloride

10% (v/v) 2-propanol

1 M Ammonium sulfate

1% w/v PEG 3350

7.5
12

0.1 M bis-Tris pH 5.5

1% w/v Polyethylene
1.0 M Succinic acid pH
13

0.1 M HEPES pH 7.0

glycol monomethyl
7.0
ether 2,000

0.2 M Ammonium

20% w/v Polyethylene

citrate tribasic pH 7.0

glycol 3,350

14

0.4 M Ammonium
15
phosphate monobasic
0.1 M Sodium acetate
16
trihydrate pH 4.6
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0.1 M MES

12% w/v Polyethylene

monohydrate pH 6.5

glycol 20,000

17

10% w/v Polyethylene
0.1 M Sodium acetate
18

glycol monomethyl
trihydrate pH 4.0
ether 2,000
0.1 M Sodium citrate
18% w/v Polyethylene

19

tribasic dihydrate pH
glycol 3,350
5.5
0.1 M BIS-TRIS pH

20

3% v/v Polyethylene
28% v/v 2-Propanol

6.5

glycol 200

0.1 M Imidazole pH
20% v/v Jeffamine ®
21

7.0
ED-2001 pH 7.0

100 mM Sodium
1000 mM Ammonium
22

acetate/ Acetic acid pH
phosphate dibasic
4.5
100 mM Imidazole/

23

Hydrochloric acid pH

10% (v/v) 2-propanol

8.0
0.1 M Sodium citrate
22% w/v Polyethylene
24

tribasic dihydrate pH
glycol 1,000
5.5
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0.4 M Potassium
25

sodium tartrate
tetrahydrate
0.1 M Imidazole pH
1.0 M Sodium acetate

26

6.5
trihydrate

0.1 M Sodium citrate
27

tribasic dihydrate pH

20% v/v 2-Propanol

5.6
0.1 M Sodium citrate
2% v/v Ethylene imine
28

tribasic dihydrate pH

0.5 M Sodium chloride
polymer

5.6
0.1 M tri-Sodium
29

20% w/v PEG 3000
citrate pH 5.5
0.2 M di-Ammonium

30

20% w/v PEG 3350
citrate pH 5.0
0.1 M Succinic acid pH

31

15% w/v PEG 3350
7.0
0.1 M Ammonium

32

0.1 M bis-Tris pH 5.5

17% w/v PEG 10,000
acetate
0.2 M Ammonium

33

0.1 M bis-Tris pH 5.5

25% w/v PEG 3350
sulfate
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0.2 M Magnesium
34

0.1 M bis-Tris pH 5.5

25% w/v PEG 3350
chloride

0.1 M BIS-TRIS pH

0.3 M Magnesium

5.5

formate dihydrate

35

36

1.0 M Ammonium

0.5% w/v Polyethylene

sulfate

glycol 8,000

0.2 M Ammonium

20% w/v Polyethylene

citrate tribasic pH 7.0

glycol 3,350

0.1 M BIS-TRIS pH

0.1 M Ammonium

17% w/v Polyethylene

5.5

acetate

glycol 10,000

0.1 M HEPES pH 7.0

37

38

39

0.1 M Sodium citrate

30% v/v Polyethylene

tribasic dihydrate pH

glycol monomethyl

5.0

ether 550
4% w/v Polyethylene

40

0.1 M HEPES pH 7.5
glycol 8,000
0.1 M Imidazole pH
12% w/v Polyethylene

41

7.0
glycol 20,000

0.1 M Sodium citrate
42

0.10% w/v n-Octyl-b-

22% w/v Polyethylene

D-glucoside

glycol 3,350

tribasic dihydrate pH
5.5
0.1 M HEPES pH 7.5

10% w/v PEG 8000,

43
8% v/v Ethylene glycol
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0.1 M Phosphate-citrate

40% v/v PEG 300

44
pH 4.2
45

46

0.1 M Imidazole pH 8

10% w/v PEG 8000
0.02 M Magnesium

22% w/v Polyacrylic

chloride

acid 5100 sodium salt

0.1 M HEPES pH 7.5

47

35% v/v 1,4-Dioxane
20% w/v Polyethylene
0.1 M MES

48

glycol monomethyl
monohydrate pH 6.0
ether 2,000

Supplemental Table 4.3 Customized crystallization screen for VPS13’s WD40 dimer.
Conditions for 3D crystals are bolded.
B1; S1; B2; S1; B3; S1; B4; S1; B5; S1; B1; S2; B2; S2; B3; S2; B4; S2; B5; S2;
B1;

B2; S3; B3; S3; B4; S3; B5;

S3;

S3;

B1; P1

B2; P1

B3; P1

B4; P1

B5; P1

B1; S4; B2; S4; B3; S4; B4; S4; B5; S4;

B1; P2; B2; P2; B3; P2; B4; P2; B5; P2;

B1; S1; B2; S1; B3; S1; B4; S1; B5; S1; B1; S2; B2; S2; B3; S2; B4; S2; B5; S2;
P1

P1

P1

P1

P1

P1

P1

P1

P1

P1

B1; S3; B2; S3; B3; S3; B4; S3; B5; S3; B1; S4; B2; S4; B3; S4; B4; S4; B5; S4;
P1

P1

P1

P1

P1

P1
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P1

P1

P1

P1

B1; S1; B2; S1; B3; S1; B4; S1; B5; S1; B1; S2; B2; S2; B3; S2; B4; S2; B5; S2;
P2;

P2;

P2;

P2;

P2;

P2;

P2;

P2;

P2;

P2;

B1; S3; B2; S3; B3; S3; B4; S3; B5; S3; B1; S4; B2; S4; B3; S4; B4; S4; B5; S4;
P2;

P2;

P2;

P2;

P2;

P2;

P2;

P2;

P2;

P2;

B1: imidazole pH 7.5 100mM, B2: Bis-tris pH 6.5 100mM, B3: Sodium Citrate pH 5.0
100mM, B4: Ammonium Citrate pH 5.0 100mM, B5: HEPES Ph 7.5 100mM,
S1: Potassium Sodium tartrate 400mM, S2: Ammonium phosphate 500mM, S3: Lithium
Sulfate 100mM, S4: Ammonium tartrate 400mM
P1: 2-propanol 10%, P2: PEG300 20%

Supplemental Table 4.4 Cryo grid freezing conditions for PxP-WD40
Grid

Glow

Temperature

type

Discharge

Humidity

30s

4℃/90%

Protein Force Time

Negative

Glacios

stain

Check

Looks

All

good

black

Detergent

Quantifoil
R1.2/1.3
WD40
-2

2s

300

dimer
Mesh,
Copper
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None

Quantifoil
R1.2/1.3
WD40
-2

2s

300

30s

0.02%

Looks

All

OG

good

black

Looks

All

good

black

4℃/90%

dimer
Mesh,
Copper
Quantifoil
R1.2/1.3
WD40
-2

5s

300

30s

4℃/90%

None

dimer
Mesh,
Copper
Quantifoil
R1.2/1.3

No

WD40

0.02%
-2

5s

300

30s

dimer

4℃/90%

particles
OG

Mesh,

Looks
good
in hole

Copper
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A

B

C

Figure 4.1 (A) Schematic of the putative domain architecture of Chaetomium thermophilum
VPS13 protein. Position of the boundaries of domains are indicated; (B) Superdex 200 10/30
chromatography profile of WD40 domain (construct information: CT-VPS13-1944-26356xHis). Peak position at around 15ml. (C) SDS gel electrophoresis of peak fractions. Position
of protein markers are indicated.
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Figure 4.2 Comparison of Superdex 200 10/30 chromatography profile of
WD40 domain (construct information: CT-VPS13-1944-2635-6xHis) and
PxP-WD40 domain (construct information: CT-VPS13-PxP-5 amino acid
linker – 1944 – 2635 – 6xHis). WD40 domain has a peak at 15ml while
PxP-WD40’s peak position is around 13ml.
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Figure 4.3 2D class averages of WD40 domain, PxP–WD40 and WD40–PxP. Scale
bar is indicated. WD40 and WD40–PxP adopt the shape of a semi-circle ring. PxP–
WD40 forms a dimer.
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Figure 4.4 Native PxP-WD40 protein crystals diffract to 3.5 Å in-house. Crystals
were serially dipped into crystallization buffer supplemented with 5% glycerol, 10%
glycerol, 15% glycerol and then 20% glycerol. The crystal was then exposed to
Rigaku X-ray Generator for 300s and the diffraction data (the two frames are 90°
apart) was collected with a Pilatus 200k Pixel Array Detector. Preliminary analysis
suggests the crystals may be monoclinic (P2) with a = 80.18, b = 168.79, c = 80.41 or
Orthorhombic (C2221) with a = 108.61, b = 117.46, c = 168.38.
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Figure 4.5 Heavy metal screen of PxP–WD40. Purified protein was incubated with heavy metal
solutions (concentrations are indicated below) with a ratio of 1:1. Shift of protein bands on native gel
electrophoresis indicates the heavy metal binding. Native: native protein; Au-1: KAu(CN)2, 1mM;
Au-2: KAuCl4 • xH2O, 1mM; Au-3: NaAuCl4 • 2H2O, 1mM; Au-4: AuCl3, 1mM; Au-5: HAuCl4 •
3H2O, 1mM; Au-6: KAuBr4 • 2H2O, 1mM; Hg-1: C13H17HgNO6 1mM; Hg-2: C2H5HgH2PO4,
1mM; Hg-3: HgCl2, 1mM; Hg-4: Hg(OOCCH3)2, 1mM; Hg-5: C9H9HgNaO2S, 1mM; Hg-6:
C8H8HgO2, 0.3mM; Hg-7: K2HgI4, 1mM; Hg-8: HgBr2, 0.5mM; Hg-9: Hg(NO3)2 • H2O, 1mM;
Hg-10: HgO, 1mM; Tl-1: Tl(O2C2H3)3 • xH2O, 1mM; Pb-1: Pb(CH3COO)2 • 3H2O, 1mM; Pb-2:
Pb(NO3)2, 1mM; Pb-3: PbCl2, 1mM; Ag-1: AgNO3, 1mM; Cd-1: CdCl2 • xH2O, 1mM; Cd-2:
CdI2, 1mM; Ir-1: K2IrCl6, 1mM; Ir-2: K3Ir(NO2)6, 1mM; Os-1:K2OsO4 • 2H2O, 1mM;
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Figure 4.6 Heavy metal screen of PxP–WD40, continued from last figure.
Native: native protein; Os-1: (NH4)2OsBr6, 1mM; Os-2: K2OsCl6 1mM; Os-3: OsCl3 •
xH2O 1mM; Pb-1: CH3CO2Pb(CH3)3 2mM; W-1: Na2WO4 • 2H2O 5mM; W-2:
(NH4)2WS4 , 5mM; Sm-1: SmCl3 • 6H2O 5mM; Sm-2: Sm(O2C2H3)3 • xH2O 5mM;
Sm-3: Sm(NO3)3 • 6H2O 5mM; La-1: La(NO3)3 • 6H2O 5mM; Eu-1: Eu(NO3)3 • 6H2O
5mM; Eu-2: EuCl3 • 6H2O 5mM; Gd-1: GdCl3 • xH2O 5mM; Lu-1: LuCl3 • 6H2O 5mM;
Lu-2: Lu(O2C2H3)3 • Xh2o 5mM; Yb-1: YbCl3 • Xh2O 5mM; Dy-1: DyCl3 • 6H2O
5mM; Pr-1: PrCl3 • 7H2O 5mM; Nd-2: NdCl3 • Xh2o 5mM; Ho-1: HoCl3 • 6H2O 5mM;
Re-1: K2ReCl6 1mM;
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